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CHAPTER 1 INTRODUCTION
Regulatory factors such as transcriptional activators or repressors and
chromatin modifiers identify their target sequences in the chromatin with high
fidelity, ensuring appropriate gene regulation. Misregulation of gene expression
can be catastrophic leading to birth defects, developmental abnormalities and
cancer. How the fidelity of regulatory factors for their target chromatin is
maintained is thus a very important aspect of gene regulation, but it remains
insufficiently understood.

A particularly useful, genetically tractable model

system to study this aspect of gene regulation is the dosage compensated X
chromosome

in

Drosophila

melanogaster

males.

In

fruit

fly

dosage

compensation, all the genes on the single male X chromosome are upregulated
approximately twofold, via chromatin modifications, to equalize gene dosage with
the two X chromosomes of females. Thus this process calls for highly selective
identification of the X chromosome in the nucleus by the dosage compensating
machinery.
Dosage compensation in Drosophila melanogaster
The MSL (Male Specific Lethal) complex brings about dosage
compensation in Drosophila melanogaster (GELBART and KURODA, 2009).
The MSL complex is composed of five proteins MSL1, -2 and -3 (Male-Specific
Lethal1, -2 and -3), MLE (Maleless) and MOF (Males absent On the First); and
one of two functionally redundant long non-coding roX (RNA on the X) RNAs,
roX1 and roX2 (reviewed by GELBART and KURODA, 2009). MOF is a histone
acetyl transferase responsible for the deposition of the activating H4K16

2
acetylation mark (SMITH et. al., 2000; AKHTAR and BECKER, 2000). CLAMP
(Chromatin-Linked Adaptor for MSL Proteins) is a recently identified protein
crucial for recruitment of the MSL complex. CLAMP tethers the MSL complex to
the X chromosome by directly binding to specific DNA motifs (SORUCO et. al.,
2013). Other trans-acting factors associated with the MSL complex are JIL-1
kinase, which brings about H3S10 phosphorylation, another histone mark
associated with increased gene transcription (JIN et. al., 2000; WANG et.al.,
2001). The NSL1 (Non-Specific Lethal 1) complex is a non-sex specific
transcriptional regulator in fruit flies, and it shares the MOF subunit with the MSL
complex (RAJA et. al., 2010). It is enriched at MSL-complex binding sites on the
X chromosome and is involved in recruitment of the MSL complex (LARSCHAN
et. al., 2012). In addition, DNA Supercoiling factor (SCF) and Topoisomerase II
are also enriched on the male X chromosome and required for proper dosage
compensation in Drosophila melanogaster (FURUHASHI et. al., 2006; CUGUSI
et. al., 2013). Thus the long non-coding roX RNAs and several protein factors
cooperate to bring about upregulation of the male X chromosome in a highly
regulated fashion.
Various models have been proposed to explain how the MSL complex
modulates

RNA

polymerase

II

(RNA

pol

II)

activity

to

bring

about

hypertranscription of X-linked genes. The transcription elongation model states
that H4K16ac leads to a reduction in torsional resistance for RNA pol II during
transcription, leading to increased expression (LARSCHAN et. al., 2011). The
discovery of a statistically significant enrichment of stalled RNA pol II at the
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promoters of X-linked genes led to the controversial promoter proximal RNA pol
II enrichment model, based solely on increased initiation of transcription
(CONRAD et. al., 2012; VAQUERIZAS et. al., 2013). The “Jump start and gain”
model is based on an increased rate of release of RNA Pol II from its paused
state at the promoters of X-linked genes, and an H4K16ac-dependent decrease
in early termination of transcription (FERRARI et. al., 2013). The exact
mechanism, however, remains elusive and could be a combination of several
different factors (reviewed in VENSKO and STONE, 2015).
Selective identification of the X chromosome
Appropriate execution of fruit fly dosage compensation entails highly
selective identification of the X chromosome in the interphase nucleus, and this is
a multistep process. The MSL complex is thought to initially assemble at sites of
roX transcription (KELLEY et. al., 1999; BAI et. al., 2004). This is followed by
recruitment to ~ 150 CLAMP-bound Chromatin Entry Sites (CESs). CESs contain
a 21bp, GA-rich motif called the MSL Recognition Element (MRE) that is bound
by the CLAMP protein (ALEKSEYENKO et. al., 2008; SORUCO et. al., 2013).
From the CESs, the MSL complex spreads in a sequence independent fashion to
actively transcribed genes in the vicinity (ALEKSEYENKO et. al., 2006). This
spreading depends on the chromo-domain of the MSL3 protein, which binds to
the co-transcriptional H3K36me3 mark associated with gene bodies of active
genes (LARSCHAN et. al., 2007; SURAL et. al., 2008).
Although these crucial findings over the years have helped to elucidate
how the recruitment and spreading of the MSL complex take place, the
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mechanism by which it targets the X chromosome with exceptional specificity
remains unknown. MREs are present on all chromosomes and are only modestly
enriched on the X chromosome (ALEKSEYENKO et. al., 2008). In addition,
besides being essential in both sexes, CLAMP also binds autosomal MREs
(SORUCO et. al., 2013). These findings rule out the MRE motif and CLAMP
binding as factors that specify X-identity.
In mammalian dosage compensation, expression of the long non-coding
Xist (X-inactive specific transcript) transcript marks the X chromosome for
inactivation (BROWN et. al., 1991; BROCKDORF et. al., 1991). The location of
both roX genes on the X chromosome in fruit flies suggests a similar role in
marking the X for compensation. However, roX RNA transcribed from an
autosomal roX transgene can restore dosage compensation to the X
chromosome, when both endogenous roX genes are mutated (MELLER and
RATTNER, 2002). It has been proposed that MSL complexes assembled at
distant autosomal loci or within the nucleoplasm can travel through the
nucleoplasm to dosage compensate genes on the X chromosome in trans (PARK
et. al., 2002). The roX loci thus do not confer X-identity. How the MSL complex is
limited to the X-chromosome therefore remains a mystery.
Additional pathways modulating X-identification
Our lab discovered a genetic interaction between components of the
siRNA pathway and dosage compensation in fruit flies (MENON and MELLER,
2009). Although without a distinct, male-limited phenotype in otherwise wild type
males, mutations in certain siRNA pathway proteins elevated mislocalization of
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the MSL complex on polytene chromosomes and increased male lethality in a
sensitized, partial loss of function roX1roX2 genetic background (MENON and
MELLER, 2009). This suggested a role for the siRNA pathway in X chromosome
recognition and led to a search for the source of the siRNA. A strong candidate
was a family of satellite repeats with near-exclusive distribution on the X
chromosome. While related repeats are also present in euchromatin and
heterochromatin on chromosomes 2 and 3, the X-linked satellites cluster within
multiple branches of a phylogenetic maximum likelihood tree (KUHN et. al.,
2012). We have designated the X-linked satellite repeat families together as
1.688X. These X-linked satellite repeats, which band in CsCl gradients at
1.688g/cm3, had been identified previously and were speculated to play a role in
dosage compensation (WARING and POLLACK, 1987; DIBARTOLOMIES et. al.,
1992). Our lab showed that ectopic expression of double-stranded hairpin RNA
(hpRNA) from a repeat cluster at cytological position 3F (1.6883F) partially
restored MSL complex localization to the X chromosome and enhanced the
survival of roX1roX2 mutant males (MENON et. al., 2014). These findings led to
the hypothesis that the 1.688X satellite repeats confer X-identity, thus contributing
to X-recognition in dosage compensation. The widespread distribution of 1.688X
repeats on the X chromosome precluded deletion studies. Instead, we devised
an alternative way of testing their functionality as cis-regulatory sequences.
Functional investigations of 1.688X repeat clusters
The objective of my dissertation is to determine if 1.688X repeats do
indeed act in cis to direct dosage compensation to nearby chromatin. I designed
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a functional test that detects compensation of autosomal chromatin. This
required generation of large, lethal autosomal deficiencies. Recruitment of
compensation to the intact homolog would rescue males, but not females. I used
FLP-FRT mediated recombination to generate translocations of large fragments
of DNA between the 2nd and Y chromosomes. These translocations are
maintained over an msl-1 mutation, thus eliminating the need for selection. The
two halves of the translocation can be separated meiotically to generate a
duplication and a deficiency. Generation and maintenance of such large, lethal
deficiencies is technically challenging, and the methodology for this is described
in Chapter 2 (JOSHI et. al., 2014).
Next I generated a transgene carrying roX1 and 1.6883F, and integrated it
on chromosome 2L. This transgene was constructed with LoxP and FRT sites,
enabling removal of 1.6883F and roX1, respectively, from the transgene; such
that the role of each element could be tested individually. I discovered that all
transgenes, including 1.6883F only, recruited the MSL complex near the 2L
insertion site and increased the expression of nearby genes. When placed
opposite the lethal deficiency, the transgenes partially rescued male flies to the
pharate stage. Females do not assemble the MSL complex, and were not
rescued by the presence of these transgenes. Additionally, all transgenes led to
a dramatic increase in recovery of male third instar larvae, which was further
enhanced by expression of 1.6883F hpRNA. My findings strongly suggest that the
1.688X repeats act in cis to facilitate X-identification and dosage compensation.
These results are included in Chapter 3, a manuscript in preparation. They also
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suggest that 1.688X repeats on the X are the targets of the siRNA pathway that
contributes to X-recognition.
The 1.6883F repeat cluster shares 95% homology to 1.6884A. Indeed,
1.6884A is the only repeat cluster with >90% identity to 1.6883F. 1.6883F and
1.6884A flank the roX1 gene. This prompted us to ask if these two clusters share
a redundant function in generation of the siRNA that promotes X chromosome
recognition. To test this idea, I worked with an undergraduate honors student,
L.Spencer, to delete 1.6884A. This was accomplished in flies that lacked 1.6883F,
using the CRISPR/Cas9 system. Flies deleted for both repeat clusters did not
show an apparent defect in male survival, and survival of females forced to
inappropriately

dosage

compensate

was

not

enhanced.

Therefore

the

specialized role of 1.6883F, and whether it is unique from other 1.688X repeats,
remains ambiguous. This study comprises Chapter 4.
In chapter 5 I summarize my findings, and discuss the scientific questions
raised and perspectives for future studies.
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CHAPTER 2 A STRATEGY FOR GENERATION AND BALANCING OF
AUTOSOME: Y CHROMOSOME TRANSLOCATIONS
This chapter has been published as: A strategy for generation and
balancing of autosome: Y chromosome translocations, JOSHI S.S., CHEONG H.
and MELLER V.H., Fly (AUSTIN). 2014; 8(1): 58-62
ABSTRACT
We describe a method for generation and maintenance of translocations
that move large autosomal segments onto the Y chromosome. Using this
strategy we produced (2;Y) translocations that relocate between 1.5 and 4.8 Mb
of the 2nd chromosome. All translocations were easily balanced over a malespecific lethal 1 (msl-1) mutant chromosome. Both halves of the translocation
carry visible markers, as well as P-element ends that enable molecular
confirmation. Halves of these translocations can be separated to produce
offspring with duplications and with lethal second chromosome deficiencies.
Such large deficiencies are otherwise tedious to generate and maintain.
INTRODUCTION
Translocations

are

traditionally

generated

by

randomly

induced

chromosome breakage. Use of the site-specific FLIP recombinase (FLP), which
recombines FLP recombination target (FRT) sites, was pioneered by Golic and
Lindquist, and has been widely used for generation of deficiencies with defined
end points (GOLIC and LINDQUIST, 1989; RYDER et. al., 2004; RYDER et. al.,
2007). This method also enables recombination between non-homologous
chromosomes, but at a lower efficiency (BEUMER et. al., 1998). Translocations
that move autosomal material onto the sex chromosomes allow predictable
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transmission of material now linked to the X or Y chromosome, making these
particularly useful. We obtained insertions of FRT in G9a, situated at 1A1 on the
tip of the X chromosome, for the purpose of generating X;A translocations.
However, one of these insertions segregates with the Y chromosome, and in fact
is inserted in a duplication of the X on the Y chromosome (Dp(1;Y)y+). The
duplicated region comprises 1A1–1B, and includes y+. Using this Y-linked FRT
site as one endpoint, we generated large translocations between the Y and 2nd
chromosomes with an efficiency similar to that for production of autosome to X
translocations (BEUMER et. al., 1998). Both halves of these translocations carry
visible markers, enabling maintenance by selection. Full translocations were
easily balanced over the male-specific lethal 1(msl-1) mutation for maintenance
without selection.
MATERIALS AND METHODS
Flies were maintained at 25°C on standard cornmeal agar food. All fly
strains used in this study are presented in Table 2.1. Matings to generate
translocations were set with 5 males and approximately 20 yw females per vial. A
generalized overview of the mating scheme used to produce T (2:Y) is presented
in Fig. 2.1. Primers for molecular characterization are presented in Table 2.2.
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Description
P{RS5} on Y

P{RS3} at 22A2
P{RS3} at 25B1
P{RS3} at 56C6
P{RS3} at 57B1
3rd chr FLP
X-linked FLP
msl-1

Stock #,
supplier
43649
(BDSC)
125639
(DGRC)
124255
(DGRC)
124291
(DGRC)
124216
(DGRC)
123609
(DGRC)
8705
(BDSC)
8727
(BDSC)
-

Genotype

Flybase Id #

Dp(1;Y)y[+],P{w[+mW.Scer\FR FBab0010476;
T.hs] = RS5} G9a[5-HA-2731] FBti0059095
y[+]/w[1118]
w[1118];P{RS3}CG18131
[CB6892–3]
w[1118];P{RS3}CG3036 [UM8026–3]
w[1118]; P{RS3}CB-6775–3

FBti0059228

w[1118]; P{RS3}CB-5407–3

FBti0028557

w[*]; wg[Sp-1]/CyO; P{w[+mC]
= ovo-FLP.R}F1A
P{w[+mC] = ovo-FLP.R}M1A,
w[*]
y w; msl11/CyO

FBti0072900

FBti0029115
FBti0058933

FBti0072898
-

Table 2.1. Full genotype and stock numbers of Drosophila melanogaster
strains used in this study.
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Fig. 2.1. Mating scheme used to generate T(2;Y) translocations. The 3rd
chromosome FLP source, [w+ovo-FLP], was balanced over TM3-Ser1 to enable
translocations to be positively identified. In practice, the eye color of
translocations is sufficiently dark as to be readily distinguished in the [w+ovoFLP] background.
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P-element end

Primer

Sequence

Proximal 1A1

Plac1(+)

CCAAGGCTGCACCCAAGGCTCTGCTCCCAC

1A1_R1

CGTTCTGCCGGCAGCGAAGTCGACTG

Pry4(+)

TAATCAACAATCATATCGCTGTCTCACTCAG

1A1_F1

GAAGTGCGTGCGTGTGCGTGCGTC

Proximal 2L at

Pry4(+)

TAATCAACAATCATATCGCTGTCTCAC

22A2

22A2_R1

GTGCTGCCCATCATCCTTATGCC

Distal 2L at

Plac1(+)

CCAAGGCTGCACCCAAGGCTCTGCTCCCAC

22A2

22A2 _F1

CCGTCGCCTGCTGTGTACCGC

Distal 1A1

Table 2.2. Primers used for molecular characterization of translocations.
Pair of primers used at each P-element end is shown.
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RESULTS AND DISCUSSION
We obtained insertions of specialized P-elements, P{RS3} and P{RS5},
for the purpose of generating translocations (described in GOLIC and GOLIC,
1996; see Table 2.1 for stock descriptions). These elements have FRT sites
flanking the 5′ exon or 3′ exon, respectively, of the mini-white gene. Flies carrying
intact elements have dark red eyes. FLP-mediated recombination between the
flanking FRT sites deletes one exon to generate reduced P{RS3r} and P{RS5r}
elements, which retain a single FRT site and the 3′ (RS3r) or the 5′ (RS5r) exons
of the mini-white gene. Flies with reduced elements have white eyes.
We used P{RS3} elements with insertion sites at cytological positions
22A2 and 25B1 on 2L , and 56C6 and 57B1 on 2R from the Drosophila Genetic
Resource Center (DGRC, Kyoto, Japan). Two P{RS5} elements inserted in G9a
at cytological position 1A1 on the tip of the X chromosome were also obtained.
Although these elements were believed to be close to one another, the miniwhite marker of one segregated with the Y chromosome (DGRC Stock# 125639).
PCR confirmed that this stock had a P-element in G9a, as well as a copy of G9a
lacking the insertion. This is consistent with insertion on Dp(1;Y)y+, the Y
chromosome present in the strain used to generate the original insertions, which
carries 1A1–1B on the Y chromosome (personal communication, K Cook). This
insertion has been renamed Dp(1;Y)y+, P{w[+mW.Scer\FRT.hs]=RS5}G9a[5-HA2731] y+ /w1118 and is now available from the Bloomington Drosophila Stock
Center (BDSC #3649). We performed matings to determine whether the Y–linked
FRT site could recombine with autosomal sites. The Golic laboratory has
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demonstrated that the recovery of recombinants between non-homologous
chromosomes is dramatically enhanced by a third FRT site (BEUMER et. al.,
1998). In accord with these findings, we were unable to obtain 2;Y translocations
with 2 FRT sites (approximately 348 vials screened). We then generated flies
carrying the Y–linked P{RS5r} element and 2 second chromosome P{RS3r}
elements, one on 2L and one on 2R . Both P{RS3r} elements were oriented to
enable production of 2;Y

translocations (Fig.2.1). Cytological and molecular

analysis was then used to identify the 2nd chromosome break point. The number
of vials scored for each set of endpoints and the translocations recovered are
presented in Table 2.3.
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2nd chromosome

# Vials

Translocations

Rate of recovery

FRT sites

scored

recovered (#)

of translocations

22A2 and 56C6

140

22A2 (3)

2.14%

22A2 and 57B1

107

0

-

25B1 and 56B6

105

0

-

25B1 and 57B1

238

57B1 (1), 25B1 (1)

0.84%

All

590

5

0.85%

Table 2.3. Summary of recovery of translocations in this study. All dysgenic
males carried a Y-linked FRT site and the indicated FRT sites on 2L and 2R. The
rate of recovery of translocations was (# independently recovered translocations/
# vials scored)*100.
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FLP-mediated recombination between P{RS5r} and

P{RS3r} elements

restores the mini-white marker, which segregates with the 2nd chromosome
endpoint. Regeneration of w+ made it possible to rapidly screen for
recombinants, as only recombinant flies had deep red eyes. Our mating utilized a
3rd chromosome source of ovoFLP in an element that itself produced a deep
orange eye color. A Serrate balancer, TM3-Ser1, was introduced to distinguish
recombinants from flies carrying the FLP source. However, this proved
unnecessary, as the reconstituted w+ marker was distinctive even in flies
retaining the FLP chromosome. Use of an X –linked FLP source (BDSC # 8727)
would obviate the need to distinguish male offspring with light and dark eyes. The
Y-linked half of the translocation can be followed by the y+ marker, which
continues to segregate with the Y chromosome. Both halves of the translocation
are thus marked, making it possible to follow them independently in a yw
background. Furthermore, each half of the translocation can be molecularly
confirmed by amplification with genomic primers flanking the insertion sites and
outward facing primers in the P{RS5} and P{RS3} elements (Fig. 2.2). Outward
facing primers within each P-element and in flanking genomic sequence were
used to confirm the second chromosome break point. A schematic of
translocation between the Y-linked 1A1 insertion and the 22A2 insertion on 2L is
depicted in Figure 2.2. Flies with both ends of the translocation were w+y+, and,
when used as template for PCR amplification, produced amplicons from proximal
and distal P-element ends for the 1A1 and 22A2 insertions (Fig. 2.2B). Males
with 2 wild type second chromosomes, and thus carrying half of the translocation
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as a duplication on the Y chromosome, were wy+. As expected, these males
lacked PCR products from the distal end of the insertion in G9a and the proximal
end of the second chromosome insertion (Fig. 2.2B). No adult w+y females were
recovered from these stocks, indicating that these deficiencies are completely
lethal.
We recovered 5 independent (2;Y) translocations with endpoints at 22A2
(3), 25B1 (1), and 57B1 (1). Translocations were named by the 2nd chromosome
break point, for example, T(2;Y) 25B1 . The rate of recovery of translocations
was 0.85% (# independently recovered translocations/ # vials scored)*100 (Table
2.3). This is comparable to previously reported translocation rates of 0.33 to
0.97% (BEUMER et. al., 1998).

18

Fig. 2.2. Molecular characterization of T(2;Y)22A2. (A) The insertion of
P{RS5r} in G9a is in Dp(X;Y)y+, containing 1A1–1B. The relative position of the
y+ marker is depicted with respect to P{RS5r} (triangle) and the junction between
X and Y material (zigzag). Primers that amplify proximal and distal ends of all
insertions were used; for simplicity, only those that amplify distal 1A1 (D 1A1)
and proximal P{RS3r} at 22A2 (P 22A2) are depicted. Upon translocation, w+ is
reconstituted on the second chromosome. The template amplified by distal 1A1
primers is now at the tip of the second chromosome. Separation of the
translocation halves to produce Dp(2;Y) 22A2 removes the distal 1A1 and
proximal 22A2 templates, but proximal 1A1 and distal 22A2 templates (primers
not shown) are retained. (B) Amplicons produced by a fly carrying the complete
T(2;Y)22A2 translocation (top). All four P-element ends are detected. Amplicons
from a Dp(2;Y)22A2 fly identify only the proximal end of the Y-linked 1A1
insertion and the distal end of the 22A2 insertion (bottom).
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Both halves of translocations are clearly visible on polytene squashes
(Fig. 2.3A and B). All 3 translocations can be separated to create viable
(Dp(2;Y)22A2) or subviable (Dp(2;Y)25B1 and Dp(2;Y)57B1) duplications.
Duplications can sometimes be observed pairing with the wild type 2nd
chromosomes (Fig. 2.3C). Translocation moves an X telomere from the Y
chromosome to the tip of the truncated 2nd chromosome. This can be seen in a
polytene preparation from the T(2;Y)57B1 translocation (Fig. 2.3D). Importantly,
both translocation and duplication males retain all fertility factors on the Y
chromosome, and are thus fertile.
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Fig.2.3. Cytological characterization of 2;Y translocations. (A) Polytene
preparations from a male larva with the T(2;Y) 22A2 translocation display one 2nd
chromosome truncated at 22A2 (arrow). (B) The other half of the translocation is
seen protruding from the chromocenter. (C) A male with Dp(2;Y)22A2 shows
pairing of the duplication with both wild type homologs (black arrow). A visible
connection between the duplication and the chromocenter is marked by a white
arrowhead. (D) Translocation moves the X telomere from the Y chromosome to
the second. This is marked by a white arrow in a T(2;Y)57B1 male. A white
arrowhead marks the 2L telomere on the normal homolog.
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The w+ and y+ markers associated with each half of these translocations
make it possible to maintain them by selection in a yw background. However,
Dp(2;Y)22A2 is viable, indicating that smaller translocations will be at a risk for
loss without selection. Translocations were initially balanced by mating
exceptional XXY females to a CyO(In(2LR)O) second chromosome. While
possible to create stocks with both sexes carrying balanced translocations, these
are plagued by low fertility. To enable easier maintenance, translocations were
balanced over an msl-1 mutation (Fig. 2.4 for mating strategy). Females
homozygous for msl-1 are fully viable and fertile, however msl-1 is male lethal
(BELOTE and LUCCHESI, 1980). The msl-1 gene, situated at 36F on 2L, is
proximal to or on the opposite arm from translocation breakpoints, and thus is
present on the translocated second chromosome but absent from separated
duplications. Stocks balanced by this method are vigorous and easily maintained.
To control the risk of recombination posed by rare XXY females, duplicate stocks
are maintained and periodically inspected. The location of other male-specific
lethal genes, such as mle (42A6) and msl-3 (65E4), suggests that all (2;Y)
translocations and (3;Y) translocations on 3R, or 3L distal to 65E4, could be
balanced by a similar strategy.
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Fig. 2.4. Balancing T(2;Y) over msl-1. Translocations were generated in a yw
background to enable detection of y+ and w+ markers. yw; msl-1 females are
mated to males carrying a full translocation (y+w+). Sons carrying the full
translocation are mated back to yw; msl-1 females to establish a stock that can
be maintained indefinitely without constant selection.
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CHAPTER 3 FUNCTIONAL ANALYSIS OF THE RECRUITMENT OF DOSAGE
COMPENSATION BY X-LINKED SATELLITE REPEATS IN DROSOPHILA
MELANOGASTER
This chapter is a manuscript in preparation (JOSHI S.S. and MELLER
V.H., in preparation)
INTRODUCTION
Drosophila melanogaster females have two X chromosomes while males
have an X and a Y chromosome. This leads to an imbalance in the ratio of X :
autosome gene dosage (DISTECHE, 2012). Males increase expression from
most X-linked genes approximately twofold in a process called dosage
compensation (DISTECHE, 2012). This is brought about by the Male Specific
Lethal (MSL) complex, which consists of five proteins and one of two redundant
long non-coding RNAs called RNA on the X 1 and -2 (roX1 and roX2). The MSL
complex modifies chromatin through deposition of the activating H4K16ac mark
(SMITH et. al., 2000). The roX RNAs are essential for proper identification and
subsequent compensation of the X chromosome in the nucleus (MELLER and
RATTNER, 2002; DENG and MELLER, 2006).
How the MSL complex is limited to the X chromosome is an intriguing and
important question that remains unanswered. Co-transcriptional assembly of the
MSL complex is thought to occur at sites of roX RNA transcription (KELLEY et.
al., 1999). This is followed by binding of the MSL complex to specific loci called
Chromatin Entry Sites (CESs), which are functionally defined by their ability to
retain binding of core MSL proteins in the absence of the complete complex
(ALEKSEYENKO et. al., 2008). CESs contain the MSL Recognition Element
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(MRE), a 21 base-pair, GA-rich, cis-acting DNA sequence required for MSL
complex binding. The CLAMP protein is bound at MREs and tethers the
assembled MSL complex (SORUCO et. al., 2013). The MSL complex then
spreads to nearby actively transcribed genes through recognition of active
chromatin marks (LARSCHAN et. al., 2007; SURAL et. al., 2008). This elegant
model suffers from major drawbacks. For example, X-identification cannot be
attributed solely to MREs, since they are only ~2 fold enriched on the X
chromosome as compared to autosomes (ALEKSEYENKO et. al., 2006). The
discovery of the zinc-finger CLAMP protein that serves as a physical mediator
between the MREs and the MSL complex was a significant finding. But CLAMPbound MREs are observed on all chromosomes, hence CLAMP does not
account for the exclusivity of the MSL complex for X chromatin (SORUCO et. al.,
2013).
The presence of the roX genes on the X chromosome suggests a role in
marking the X for compensation. Indeed, when inserted on an autosome, the roX
genes recruit the MSL complex to flanking sites and bidirectional, non-contiguous
spreading in the form of discrete polytene bands is observed (KELLEY et. al.,
1999). This could be considered analogous to the long non-coding Xist (Xinactive specific transcript) RNA that marks the inactive X chromosome in
mammalian dosage compensation. Xist is a part of the X inactivation center (Xic),
a region that is necessary and sufficient to silence the entire chromosome
(BROWN et. al., 1991; BROCKDORF et. al., 1991). However, when roX genes
are deleted from the X and placed on an autosome, the roX RNA assembles with
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the MSL complex and travels to the X chromosome, rescuing compensation.
(MELLER and RATTNER, 2002). This indicates that, unlike the XIC, the roX
genes by themselves are not sufficient to specify X identity. Exclusive Xrecognition by the MSL complex must therefore involve additional mechanisms.
Our lab has previously shown that the siRNA pathway plays a role in X
chromosome recognition during dosage compensation (MENON and MELLER,
2009). This led to a quest for the source of the small RNAs involved in this
process and the discovery that siRNA from a repetitive element that is strikingly
enriched on the X chromosome enhanced X-identification by the MSL complex
and rescued the lethality of roX1roX2 mutant males (MENON et. al., 2014).
These clusters of repetitive sequences, the 1.688X repeats, are near exclusive to
the X chromosome and unlike most satellite repeats, they are euchromatic. In
this study, we chose a functional approach to test the ability of 1.688X to recruit
dosage compensation.
We postulated that the 1.688X repeats might act cooperatively with roX
genes to identify X chromatin. The presence of hundreds of dispersed 1.688X
repeats in X euchromatin makes testing the effects of individual repeats near
impossible. Instead we tested the ability of roX1 and 1.6883F (a repeat cluster
located at cytological position 3F) to recruit compensation to an autosome. A
transgene carrying roX1 and 1.6883F was inserted on an autosome. roX1 or
1.6883F can be excised from the transgene, enabling a test of either element by
itself. The full transgene recruits the MSL complex in cis, as does roX1 alone
and, surprisingly, 1.6883F alone. All three transgenes increase expression of
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nearby genes. Remarkably, all three transgenes were able to partially rescue a
lethal autosomal deficiency of the homologous chromosome in males, but not in
females; thus demonstrating the ability to recruit functional compensation to an
autosome. We conclude that the 1.6883F repeats play a functional role in
recruitment of dosage compensation in Drosophila melanogaster males.
MATERIALS AND METHODS
Cloning and transgene integration
The [>roX1> w+mC>1.6883F >] transgene was generated in the pUASTB
vector by traditional cloning techniques (described in detail below). Injections
were performed by Genetic Services Inc. (Sudbury, MA) into stocks containing
22A3 [VK00037], 24A2 [su(HW)attP6] and 25C7 [attP40] landing sites. In-situ
hybridization to polytene preparations using a 1.6883F probe verified integration
(Appendix A).
Fly culture and strains
Flies were maintained at 25°C on standard cornmeal agar diet in a
humidified incubator. Strains carrying Df(2)22A2 have been described (JOSHI et.
al., 2014). Description of P{Sqh-mCherry.M} and P{sqh-GAL4} can be found at
flybase.org. [hp 1.6883F] has been described (MENON et. al., 2014).
Sorting and quantification of third instar larvae
Fly matings to generate scorable Df(2)22A2 male or female larvae are
presented (Fig. 3.9). Fluorescent larvae inherited the intact 2nd chromosome, and
dark larvae carried the deficiency. All third instar larvae were collected and
scored 3 times per day. Males were identified by gonad visualization. A subset of
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larvae was subjected to PCR to verify the Df(2)22A2. All non-fluorescent larvae
did carry the deficiency (data not shown).
Immunodetection
Immunhistochemical detection of MSL2 on polytene chromosomes was
done as previously described (KELLEY et al. 1999). Visualization and
photography were performed with an Olympus IX81 inverted microscope fitted
with a Photometrics CoolSNAP EZ CCD camera.
Quantitative RT-PCR
Total RNA was prepared from two biological replicates of ~50 third instar
males per genotype using the Trizol reagent (Invitrogen). One microgram of total
RNA was reverse transcribed using random hexamers and the ImProm-II reverse
transcriptase following manufacturer recommendations (Promega). Duplicate
reactions were amplified in a 20 µl volume (4 µl primer mix, 2 µl 1:10 template, 4
µl DH2O and 10 µl iTaq Universal SYBR Green Supermix from Bio-Rad) using an
Mx3000P Real-Time PCR system (Stratagene). Genes selected for analysis
were stably and moderately expressed during the third instar larval stage (genes
and primer information in Table 3.1). qRT-PCR data was analyzed by the
efficiency corrected comparative quantification method (PFAFFL 2001), primer
efficiency was incorporated into calculations. Dmn was used as the normalizing
gene. A box and whiskers plot was generated using SPSS. One-way ANOVA
was performed followed by Tukey’s HSD post-hoc tests for analysis of significant
difference between means of gene expression values. SPSS was used to
calculate Pearson correlation coefficients of relationship between change in gene
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expression, and distance from the transgene or basal expression.
Generation of the SJTG clone
The SJTG clone contains roX1 and 1.6883F, each flanked by LoxP and
FRT sites, with w+mC between them. After integration using phiC31, the transgene
had [>roX1> w+mC>1.6883F >] in the orientation shown. FRT sites were amplified
from flies containing a PBac transposable element using roX1_Frt_F and
roX1_Frt_R, and Sat_Frt_F and Sat_Frt_R, to produce FRT sites flanking roX1
and 1.6883F respectively. PCR products were cloned into the pCR4-TOPO vector
(Invitrogen). LoxP sites were amplified from the plasmid pRKO using
roX1_LoxP_F and roX1_LoxP_R, and Sat_LoxP_F and Sat_LoxP_R, to produce
LoxP sites flanking roX1 and 1.6883F respectively. PCR products were cloned
into the pCR4-TOPO vector. roX1-LoxP was excised at BamHI and NotI and
cloned into pBluescript containing a 4.9kb roX1 fragment. roX1 was then excised
from this vector using EcoRI on each side, as it contains a ClaI site. FRT was
dropped in using ClaI and SalI, and roX1 was put back using EcoRI to produce
the “LFR” clone (roX1 flanked by LoxP and FRT). Sat-LoxP was excised using
EagI and cloned into the NotI site of a pCR4-TOPO vector containing a ~2kb
1.6883F fragment. Sat-FRT was then cloned into this vector using PstI and SpeI,
generating the “LFS” clone (1.6883F flanked by LoxP and FRT). The vector
pUASTB contains P-element ends, a w+mC and an attB site (GROTH et. al.,
2004). The StuI site in pUASTB was opened and a linker was put in containing a
XhoI site, destroying the StuI site in the process. “LFS” was digested with SalI to
excise a ~2.5 kb fragment containing 1.6883F, LoxP and FRT and this fragment

29
was inserted into pUASTB at the XhoI site. This clone was then digested with
MluI; and a ~5.4 kb fragment containing roX1, LoxP and FRT was excised from
“LFR” using BssHII and inserted. The final clone, “SJTG” was thus generated.
Extensive restriction mapping, sequencing and PCR were performed at each
stage of the cloning for confirmation.
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Primer name
roX1_LoxP_F
roX1_LoxP_R
Sat_LoxP_F
Sat_LoxP_R
roX1_Frt_F
roX1_Frt_R
Sat_Frt_F
Sat_Frt_R
BPR08wh(F)
RNR1_R2
roX1HincIIR
attB_210R
BPR26
roX1R_706

Sequence
ATCGGTCGGCGGCCGCGCGCTTAATATAACTTCGTATAATGTA
GATGGATCCCCTAATAACTTCGTATAGCAT
ATCGTTCGGCCGTCGACTTAATATAACTTCGTATAATGTA
CGACCGTTGCGGCCGCCCTAATAACTTCGTATAGCAT
CCATCGATACTAGTTTCCGAAGTTCCTATTCTC
GCATGCGCGCGCGCGCTCTGAAGTTCCTATACT
GACTGCAGCGGCCGCTTCCGAAGTTCCTATTCTC
CACTAGTGTCGACGCTCTGAAGTTCCTATACT
TAGCTCCTGATCCTCTTG
AAAACAGTCTTCATTTAAGCGGTAA
CTCAATAGCATAAAAAATAGTTGACC
TGACCGTCGAGAACCCGCTGACG
GAGGTCTAGACCCACCAAAGAGGCTTGACAGAAGA
TCATATCCACTAGCATAAGGCTGGCG

Table 3.1. List of primers used in cloning and analysis of
[>roX1>w+mC>1.6883F >].
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RESULTS
Our initial working model was that the X-linked roX genes recruit
compensation in cis and X-linked satellites facilitate spreading to cover the X
chromosome. To test this we generated a transgene with roX1 and 1.6883F
[>roX1> w+mC>1.6883F >]. LoxP and FRT sites (>) enable deletion of roX1 or
1.6883F by site-specific recombination (Fig. 3.1). Excision is detected by loss of
w+mC. Genotypes of flies and excised transgenes were confirmed by PCR (data
not shown). Full and reduced transgenes were integrated on 2L at cytological
positions 22A3, 24A2 and 25C7 (superscript indicates cytological position, see
materials and methods for details). The full transgene is henceforth referred to as
[roX1+1.6883F]; and the reduced transgene with roX1 as [roX1]; and 1.6883F as
[1.6883F].
1.6883F and roX1 transgenes recruit MSL protein to autosomal sites
Male polytene chromosome preparations were made from a laboratory
reference strain with no transgenes and from strains with full or reduced
integrations at 22A3. These were immunostained for the core MSL complex
component MSL2. As expected, all polytenes showed strong recruitment to the X
chromosome. No autosomal recruitment of MSL2 to 2L was detected in the
laboratory reference strain (Fig.3.1 B, C). In contrast, males carrying complete
and reduced transgenes displayed recruitment to the tip of 2L at cytological
position 22A3 (Fig. 3.1 D-G). Quantification of the recruitment was performed
and the results are presented in Table 3.2, while examples of weak (+) to very
strong (++++) recruitment are shown in Fig. 3.2. Recruitment of MSL2 by
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[1.6883F]22A3

was

more

robust

[roX1]22A3,

than

and

comparable

to

[roX1+1.6883F]22A3. Significantly, [1.6883F]22A3 and [roX1+1.6883F]22A3 support
spreading of MSL2 into chromatin of 2L. This is particularly apparent at a strong,
subtelomeric band that is seen in most preparations with these transgenes, but
not in control males (white arrowheads, Fig. 3.1 E, G; Table 3.2). It has
previously been shown that the subtelomeric position 21B weakly recruits MSL2
in wild type males, but the low resolution of polytene preparations does not allow
us to conclude that this is identical to the subtelomeric band presently observed
(MELLER and RATTNER, 2002). Interestingly, about half the preparations of
[1.6883F ]22A3

and [roX1+1.6883F]22A3 also showed spreading to an additional

autosomal telomere, specifically 3L (white arrows, Fig. 3.3). Although [roX1]22A3
did not support robust spreading to the sub-telomeric band on 2L, ~ 20% of
preparations showed
having

the

proximal spreading on 2L. Moreover, a chromosome

complete

transgene

integrated

at

three

positions,

[roX1+1.6883F]22A3+24A2+25C7, recruited MSL2 as individual bands of comparable
intensity near each integration site, and spreading was observed in the form of a
single sub-telomeric band (data not shown).
roX transgenes, which contain CES sites, have long been known to recruit
the MSL complex and induce variable levels of MSL complex spreading into
flanking chromatin (KELLEY et al., 1999). Transgenes containing the MRE motif
also recruit the MSL complex to autosomes (ALEKSEYENKO et. al., 2008). Our
study reveals that 1.6883F, which shares no sequence similarity with CES sites or
MREs, is capable of recruiting the MSL2 protein near its site of integration when
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present on an autosome. Moreover, [1.6883F]22A3 supports spreading in cis, in the
form of additional bands on polytene chromosomes.

We conclude that the

1.6883F repeats do not merely facilitate spreading, but are themselves capable of
recruiting the MSL complex to nearby chromatin.
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Figure 3.1. Autosomal insertion of roX1 or 1.6883F recruits MSL2.
(A) Schematic of roX1 and 1.6883F transgenes. The complete transgene (top)
has roX1, w+mC and 1.6883F flanked by attL and attR sites (open rectangles).
LoxP sites (gray triangles) enable Cre-mediated excision of 1.6883F and w+mC,
producing white-eyed roX1 flies (bottom left). FRT sites (black triangles) enable
excision by FLP to remove roX1 and w+mC, to generate white-eyed 1.6883F flies
(bottom right). (B) MSL recruitment (red) is limited to the X chromosome in a
control male. (C) Enlargement of cytological position 22A3 showing absence of
MSL2 (yellow arrowhead). (D) [roX1]22A3 recruits MSL2 to a single band near
22A3. (E) [1.6883F ]22A3 recruits MSL2 robustly near the integration site (yellow
arrowhead). Spreading to a sub-telomeric region is observed (white arrowhead).
(F, G) MSL2 recruitment by [roX1+1.6883F ]22A3 is robust and similar to [1.6883F
]22A3. (G) Detail of 2L from (F). Immunostaining was performed to polytene
chromosomes from male third instar larvae. DNA is counterstained using DAPI
(blue). X-staining of all transgenic lines is indistinguishable from that in wild type
males.
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3L
telomere

Additional
signal on 2L

22A3 Recruitment

None
-

100 (63)

0 (0)

0 (0)

roX1 +
1.6883F
1.01 (1)

+

0 (0)

10.78 (11)

0 (0)

0 (0)

++

0 (0)

65.68 (67)

15.17 (17)

30.3 (30)

+++

0 (0)

23.52 (24)

55.35 (62)

59.59 (59)

++++

0 (0)

0 (0)

29.46 (33)

14.14 (14)

None

98.41 (62) 75.49 (77)

9.82 (11)

15.15 (15)

Sub-telomeric

0 (0)

6.86 (7)

89.3 (100)

78.78 (78)

Proximal to
22A3
None

1.5 (1)

19.6 (20)

8.03 (9)

4.04 (4)

98.41 (62) 95.09 (97)

49.1 (55)

45.45 (45)

One Band

1.58 (1)

3.92 (4)

50.89 (57)

54.54 (54)

3.17 (2)

36.27 (37)

7.14 (8)

9.09 (9)

100 (63)

100 (102)

100 (112)

100 (99)

63

102

112

99

Ectopic bands
on other chr
X-staining
normal
Total nuclei counted
Other

Transgene
roX1
1.6883F

Table 3.2. Autosomal MSL2 recruitment by [roX1]22A3; [1.6883F]22A3 and
[roX1+1.6883F]22A3. Recruitment close to the integration site is ranked from no
recruitment (-) to very strong (++++). Additional autosomal signals were
categorized by cytological position. Examples of the various categories of
recruitment are presented in Fig. 3.2. The percentage of nuclei in each category
is followed by the number of nuclei (parentheses). Counts were derived from 3
individuals for yw, and 5 each for [roX1]22A3; [1.6883F]22A3 and [roX1+1.6883F]22A3.
Scoring was done by a single individual on coded samples.
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+

++

++++

+++

Fig. 3.2. Examples for varying degrees of MSL2 staining by autosomal
transgenes. Representative images showing MSL2 recruitment ranging from
weak (+) to very strong (++++) as quantified in Table 3.2.
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Fig. 3.3 MSL2 spreading to the 3L telomere. MSL2 (red) is recruited by
[1.6883F ]22A3 (A) and [roX1+1.6883F ]22A3 (B). Recruitment near the integration site
(yellow arrowhead) and robust telomeric recruitment to 2L (white arrowhead) and
3L (white arrows) is observed. Immunostaining of polytene chromosomes from
male larvae used an anti-MSL2 antibody. DNA was counterstained with DAPI
(blue).
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Increased autosomal gene expression is observed near transgene
integrations
Recruitment of MSL2 to 2L by roX1 and 1.6883F integrations suggested a
possible increase in expression of nearby genes in males. To test this we
generated recombinant chromosomes with all three complete integrations
([roX1+1.6883F]22A3+24A2+25C7), increasing the number of genes near integration
sites that could be tested. Expression of Cre or FLP then produced
chromosomes

with

roX

only

([roX1]22A3+24A2+25C7)

or

1.6883F

only

([1.6883F]22A3+24A2+25C7) integrations. Quantitative RT-PCR was used to measure
expression of test genes situated near integration sites in male larvae (see Fig.
3.4 for schematic; Table 3.3 for genes and primers; Table 3.4 for relative gene
expression values). Control autosomal genes, situated far from the integration
sites (2R or 3R) showed no difference in expression between lines with
transgenes and our lab reference strain (white boxes, Fig. 3.4). In contrast,
genes near integration sites displayed a slight increase in expression in
[roX1]22A3+24A2+25C7 males (gray box, Fig. 3.4).

Interestingly, these genes

displayed a greater, statistically significant increase in

[1.6883F ]22A3+24A2+25C7

males. As expected, males with 3 copies of the full transgene had the largest
increase in expression of nearby genes (gray boxes, Fig. 3.4).
The most highly expressed gene tested, RpL37A encoding a ribosomal
subunit, displayed a 2-fold increase in expression, as would be expected from full
compensation. As local MSL complex recruitment is cotranscriptional, strong
expression of RpL37A may facilitate increased MSL complex recruitment. In
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accord with this idea, we found a positive correlation between expression relative
to Dmn in control males, and the increase in expression achieved when roX1 and
1.6883F transgenes are present (Fig.3.5 A-C). We did not, however, observe a
correlation between the distance to the nearest transgene and the increase in
expression achieved, up to a distance of 142 Kb, which is the farthest our test
genes were from the integration site. (Fig.3.5 D-F). We conclude that local MSL2
recruitment induced by roX1 and 1.6883F transgenes increases the expression of
genes in cis, reflecting the presence of an active MSL complex.
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Fig. 3.4. Expression of autosomal genes near transgene integration sites is
increased in male larvae. (A) Schematic showing test genes near transgene
integrations (black triangles) on 2L. (B) Expression was measured by quantitative
RT-PCR in third instar male larvae. The ratio of expression in males with the
indicated transgenes to control males (no transgenes) is depicted for 10 test
genes (near integration sites on 2L, gray) and 5 control genes (on 2R or 3,
white). The control genes show no significant change in expression when
transgenes are integrated on 2L. Test genes on 2L significantly increased in
expression in [1.6883F]22A3+24A2+25C7 and [roX1+1.6883F]22A3+24A2+25C7 males (*
p<0.05 and ** p<0.01 respectively).
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No TG

.6
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With TG

A

.8

D

roX1
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1.6883F
R = 0.66*
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roX1 + 1.6883F
R = 0.805*
Expression relative to Dmn
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roX1
R = 0.136
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1.6883F
R = 0.073
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roX1 + 1.6883F
R = 0.084
Distance in Kb

Fig. 3.5. 1.6883F-dependent increase in gene expression is correlated with
basal expression but not distance from nearest transgene. (A-C)
Scatterplots showing relationship between gene expression in control males (no
transgene; X-axis) and the change in expression in males with a transgene (Y-
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axis). All expression is normalized to Dmn. A significant correlation is observed
for [1.6883F]22A3+24A2+25C7 (B) and [roX1+1.6883F]22A3+24A2+25C7 (C) but not
[roX1]22A3+24A2+25C7 (A), however a trend can be observed. (D-F) Scatterplots
showing distance to nearest transgene (X-axis; in Kb) and the change in
expression in males with a transgene (Y-axis). No significant correlation was
detected in this analysis. Pairwise correlation was performed using SPSS, the
Pearson Correlation Coefficient (R) is shown. (* p < 0.05)
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Gene
name

Cytological
position

CG33128 22A2 (2L)

Primer
name

J1_F2
J1_R2

RFeSP

22A3 (2L)

J2_F3
J2_R3

Eno

22B1 (2L)

J3_F1
J3_R1

CG16704 24B1 (2L)

J4_F3
J4_R3

eIF-3p40

25C3 (2L)

J5_F2
J5_R2

His3.3A

25C3 (2L)

J6_F2
J6_R2

Rpn11

25C3 (2L)

J7_F2
J7_R2

RpL37A

25C4 (2L)

J8_F1
J8_R1

Trip1

25B5 (2L)

J9_F4
J9_R4

CG31778 24C1 (2L)

J10_F2
J10_R2

Primer sequence

AACCGACCAGAA
CCTCATCG
TCACGGTTCCAT
TCCAGGTG
AAATGATGAACG
CCGTGTCG
GCAGAGCCTTAC
CCATCGAG
ATGTCTTGGACC
GCTTCAGT
GCCCTTTCGATT
GGGGTGA
GAATGGTCTCGC
TGTGTTGTG
TAGGTCCACATG
GGTTGCAG
ACGGACTGGTG
AGTAGTGCT
CTCTACGCCCAT
GTCCTCAC
GCGTCTCTCCCC
CATTTCAA
CATAATGGTGAC
GCGCTTGG
CAGAGGTGAGC
ACTTGGCTTA
TGTGGCATAGCA
CCTCCAAG
GAGCGCCAAAT
GGTGACAAA
CAGGACCAGAT
GCCCACAAC
TCACAGGTTGGT
GTTTACCCG
GTGCCAGAGTCA
ACCACCTT
AACCATTCACTG
CAGAGGCG
CCGAAGTCATTG
CCCTCAGAA

Primer
Working
conc.
(nM)
150

Efficiency
(%)

98.4

300

89.2

150

102.1

150

106.5

150

98.3

150

106.8

150

102.7

500

108.6

500

111.8

150

95.7
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Gene
name

Dip-B

Cytological
position

87F13 (3R)

Primer
name

DipB_F
DipB_R

ATPa

93A4 (3R)

ATPa_F
ATPa_R

Xbp1

57C3-C4
(2R)

Xbp1_F
Xbp1_R

Gprk1

41B3-C2
(2R)

Gprk2_F1
Gprk2_R1

Gapdh1

43E17 (2R)

GAPDH_F
GAPDH_R

Dmn

44F3 (2R)

Dmn_F
Dmn_R

Primer sequence

Primer
Working
conc.
(nM)
AGGATCACGCCA 300
GAAGACTG
AGTCACTGGGAC
GGAGAATG
ACCCACACTGCT 300
ACACTCCC
TCCTGGTTGCTC
TTGTTGTG
GGGAGAGCAAC 300
TTTGACGAG
GCCGGCCAAAC
TTAACAATA
TCTAAAAGGCTT 300
GGGTGCAT
TGTAAACCTGGT
GCCAATCA
GCCCTGAACGG
300
CAAGCT
GTAAGATCCACA
ACGGAGACATTG
GACAAGTTGAGC 300
CGCCTTAC
CTTGGTGCTTAG
ATGACGCA

Efficiency
(%)

92.8

106.3

97.1

97.2

98.9

98.5

Table 3.3. List of primers used for quantitative RT-PCR studies. The genes on
2L were used as test genes and genes on 2R and 3R were used as controls in this
study. Dmn was used as the normalizing gene.
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Control Genes on
2R and 3R

Test Genes on 2L

Gene

Transgene
None

1.6883F

roX1

roX1+1.6883F

CG33128

1

1.263

1.11

1.208

1.326

1.425

1.337

RFeSP

1

1.192

1.242

1.368

1.29

1.63

1.49

Eno

1

1.096

1.184

1.14

1.26

1.31

1.51

CG16704

1

1.096

1.06

1.12

1.098

1.204

1.133

eIF-3p40

1

0.998

1.1

1.09

1.25

1.37

1.26

His3.3A

1

1.49

1.612

1.45

1.348

1.59

1.474

Rpn11

1

0.862

0.824

0.96

0.935

0.99

0.92

RpL37A

1

1.412

1.478

1.762

1.696

1.88

2.069

Trip1

1

1.408

1.48

1.51

1.592

1.672

1.761

CG31778

1

1.396

1.484

1.689

1.745

1.533

1.594

Xbp1

1

0.954

0.943

0.92

0.894

0.902

0.88

DipB

1

0.844

0.876

1

0.912

0.912

0.993

ATPa

1

1.178

1.192

1.107

1.11

1.116

1.143

Gprk2

1

1.115

1.084

1.098

1.12

1.108

1.033

GAPDH

1

1.102

1.196

1.086

1.162

1.14

1.092

Table 3.4. Relative gene expression values. Gene expression as measured by
quantitative RT-PCR. RNA was extracted from control male third instar larvae; or
from males with integrations of [roX1], [1.6883F], or [roX1+1.6883F] transgenes.
Expression from yw (No TG) was used as a calibrator, and Dmn was used as the
normalizer. Two biological and two technical replicates were performed.
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1.6883F and roX1 transgenes functionally compensate a 2L deficiency
To determine if the observed increase in expression of autosomal genes
constituted a functional dosage compensation system, we tested for rescue of
lethality associated with a hemizygosity of distal 2L. Males with a lethal 2nd
chromosome deficiency and a single [roX1+1.6883F]22A3 transgene on the intact
homolog opposite the deficiency were generated. As the dosage compensation
complex is only assembled in males, females are used as the control (Fig.3.6 A).
We selected a translocation (T(2;Y)22A2) that can be separated into its
constituent halves; a terminal deficiency of 1.5 Mb that is completely lethal
(Df(2)22A2), and a reciprocal duplication on the Y chromosome (Dp(2:Y)22A2)
(JOSHI et. al., 2014). Matings that separate Df(2)22A2 and Dp(2:Y)22A2
produce offspring for testing (Fig. 3.7). Df(2)22A2 has its endpoint at cytological
position 22A2, therefore we chose to test a transgene integration at 22A3.
Neither full nor reduced transgenes at 22A3 rescued Df(2)22A2 males to
adulthood. Nor could adult male survivors having Df(2)22A2 be recovered when
three copies of the transgene on 2L were integrated at 22A3, 24A2 and 25C7
(data not shown). This may be a consequence of the insertion sites at 24A2 and
25C7 being several Mb away from the deficiency endpoint that is at 22A2.
However, closer examination of the vials revealed pharate male pupae, and a
few partially eclosed males carrying Df(2)22A2 over a single integration of the
transgene at 22A3. No pharate Df(2)22A2 males were observed from matings
that lack the transgene and no pharate females could be recovered with or
without the transgene (Fig. 3.6 B; data not shown). Dissection of the pupal cases
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of pharate males revealed fully developed adults with eye color indicating the
Df(2)22A2 chromosome. The presence of Df(2)22A2 and lack of Dp(2:Y)22A2 in
these males was confirmed by PCR (Fig. 3.8). While both the partial and
complete transgenes enabled recovery of pharate males; [roX1]22A3 yielded 6%
the anticipated number of pharate males (based on survival of brothers lacking
Df(2)22A2), and [roX1+1.6883F]22A3 produced 18% pharate males.

The most

dramatic finding was that the repeats alone, [1.6883F ]22A3 produced 11% pharate
survival, exceeding rescue with roX1 alone (Fig. 3.6 B). These findings suggest
that roX1 and 1.6883F transgenes were achieving partial compensation of 2L, but
the difficulty of scoring pharate pupae prompted a switch to examination of 3rd
instar larvae.
Larval survival is enhanced by 1.6883F and roX1
To determine if differences in survival can be detected at earlier
developmental times, we sexed and genotyped all late 3rd instar larvae from
matings that produce Df(2)22A2 males and females (see Fig. 3.9 for mating
strategy). Larvae were sexed and genotyped by visible markers, and a subset of
Df(2)22A2 males were genotyped by PCR. PCR revealed the presence of the
deficiency and absence of the rescuing duplication in these males (Data not
shown). 3rd instar Df(2)22A2 females were recovered at ~ 3% the anticipated
number in vials from control matings in which no roX1or 1.6883F transgene is
present on 2L. The recovery of these females is unchanged by the
[roX1+1.6883F]22A3 integration (Fig. 3.6 C). Df(2)22A2 males with no transgene
are also recovered at ~3%. However, when [roX1]22A3 was present on the intact
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2nd chromosome, 20% of Df(2)22A2 3rd instar males were recovered (black bar,
Fig. 3.6 D). This increased to 36.5% with [1.6883F ]22A3. Optimum recovery of 51%
of 3rd instar Df(2)22A2 males was achieved with [roX1+1.6883F]22A3 (black bars,
Fig. 3.6 D). These findings confirm that the 1.6883F repeats are more effective in
recruiting compensation to nearby genes than roX1 itself.
Ectopic expression of 1.6883F siRNA enhances rescue of male larvae when
a cognate sequence is present on 2L
Our lab has previously shown that ectopic expression of hairpin RNA from
1.6883F led to production of small RNA and partially rescued the lethality of
roX1roX2 mutant males. We speculate that 1.6883F siRNA might act by triggering
modification of chromatin at related repeats throughout the X, and that these
epigenetic changes facilitate recruitment of MSL proteins to nearby genes. The
presence of 1.6883F on the autosomal transgene enabled us to test if the effect of
hp1.6883F on compensation requires cognate loci near regulated genes. If this is
the case, we would expect any effect of hp1.6883F expression to be limited to
transgenes that carry 1.6883F repeats. In accord with this prediction, ectopic
expression of 1.6883F siRNA had no effect on the recovery of male larvae
carrying Df(2)22A2 with [roX1]22A3 on the intact chromosome (gray bars, Fig. 3.6
D). However, an 8% increased recovery of larvae carrying Df(2)22A2 over
[1.6883F ]22A3 or [roX1+1.6883F]22A3 was observed when hp1.6883F was expressed
(gray bars, Fig. 3.6 D).

The effect of 1.6883F siRNA was thus limited to

transgenes containing 1.6883F. Expression of hpRNA to the non-essential white
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gene did not affect rescue by any transgene, indicating that enhanced rescue is
not an effect of non-specific small RNA production (preliminary data, not shown).
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Fig. 3.6. Insertions of roX1 and 1.6883F on 2L partially rescue males
carrying a lethal 2L deficiency. (A) Strategy to test autosomal dosage
compensation. Df(2)22A2 is lethal in both males (left, top) and females (right,
top). If a roX1 and 1.6883F transgene on the homolog recruits dosage
compensation, male-limited rescue will occur (left, bottom). Thick lines indicate
dosage compensated chromatin. (B) Pharate Df(2)22A2 males are observed only
when [roX1]22A3, [1.6883F ]22A3 or [roX1+1.6883F]22A3 is present on the homolog.
The recovery of pharate males is with respect to the number of brothers that
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emerge with the intact 2nd chromosome (See Fig. 3.7 for description of mating).
(C) Recovery of female larvae (diagonal lines) was unaffected by the presence of
[roX1+1.6883F]22A3. (D) Recovery of Df(2)22A2 male larvae is enhanced by
transgenes containing roX1 and 1.6883F, and ectopic hp1.6883F RNA. The ratio of
larvae carrying Df(2)22A2 to their siblings with an intact 2nd chromosome is
presented (See Fig. 3.9 for description of mating). 2nd chromosome integrations
of [roX1]22A3 ; [1.6883F ]22A3 and [roX1+1.6883F]22A3 significantly increased the
number of male larvae recovered (black bars). Ectopic expression of hp1.6883F
RNA further enhanced recovery of male larvae with [1.6883F ]22A3 and
[roX1+1.6883F]22A3, but not [roX1]22A3 (gray bars) (Fig. 3.10 for description of
mating). SEM represented by error bars. (* p < 0.05; ** p < 0.01; *** p < 0.001;
**** p < 0.0001).
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Fig. 3.7. Matings to test transgene rescue of male Df(2)22A2 flies. Male
Df(2)22A2 offspring were generated by mating C(1)DXyf females homozygous
for the transgene to be tested [TG] to T(2;Y)22A2 males. T(2;Y)22A2 can be
separated into Df(2)22A2 and Dp(2;Y)22A2 (JOSHI et. al., 2014). All male
progeny inherit a wild type maternal Y chromosome, the 2nd chromosome
transgene and either Df(2)22A2 (test males) or a wild type 2nd chromosome
(control males). The 2L endpoint of T(2;Y)22A2 carries a white marker,
conferring dark red eye color which enables phenotypic distinction.
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3
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Fig. 3.8. PCR genotyping of a pharate male. PCR detecting the proximal and
distal ends of the insertions used to generate T(2;Y)22A2. The translocation
occurred between an insertion in 2L and an insertion at 1A1 in a small duplication
of the distal X on the Y (JOSHI et. al., 2014). Amplicons from a representative
Df(2)22A2 pharate male are shown. The distal 1A1 (lane 3) and proximal 22A2
(lane 6) PCR products can be amplified from Df(2)22A2. The proximal 1A1 (lane
4) and the distal 22A2 (lane 5) PCR products are indicative of Dp(2;Y)22A2 and
not detected. A MW marker (lane 1) and PCR for template control (lane 2) are
shown.
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Fig. 3.9. Matings to determine recovery of Df(2)22A2 larvae. (A) Df(2)22A2
male larvae were produced by mating C(1)DXyf females with the transgene to be
tested [TG] to T(2;Y)22A2 males carrying P{Sqh-mCherry.M} on the intact 2nd
chromosome. All male progeny inherit a wild type, maternal Y chromosome, the
transgene being tested and either Df(2)22A2 or P{Sqh-mCherry.M} (control).
Males are identified by gonad visualization, and control males are detected by
mCherry fluorescence. (B) Df(2)22A2 female larvae were produced by mating
females homozygous for the transgene to be tested to T(2;Y)22A2 males
carrying P{Sqh-mCherry.M} on the intact 2nd chromosome. All female progeny
inherit one copy of the transgene and either Df(2)22A2 or P{Sqh-mCherry.M}
(control). Control females are detected by mCherry fluorescence.
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Fig. 3.10. Matings to determine effect of hp1.6883F RNA on recovery of
Df(2)22A2 males. C(1)DXyf females homozygous for the transgene to be tested
were mated to T(2;Y)22A2 males carrying a UASgal-driven hp1.6883F RNA
transgene (MENON et. al., 2014), and [Sqh-Gal4] on the X chromosome. P{SqhmCherry.M} marks the intact 2nd chromosome. All male progeny ectopically
express hp1.6883F, carry a wild type Y chromosome, a 2nd chromosome
transgene and either Df(2)22A2 or P{Sqh-mCherry.M} (control). Control males
are detected by mCherry fluorescence.
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We conclude that 1.6883F functions as a cis-acting element for recruitment
of the MSL complex, and dosage compensation, to flanking chromatin. The
enrichment of related elements on the X chromosome suggests that this family
broadly serves to mark X chromatin. Enhancement of rescue by hpRNA from
1.6883F is limited to transgenes with cognate repeats suggesting that the siRNA
pathway acts in dosage compensation via targeting of cognate loci on the X
chromosome.
DISCUSSION
Although the MSL complex perfectly identifies active X chromatin in the
interphase nucleus, how the appropriate selectivity is achieved remains
mysterious. In this study, we have demonstrated that the 1.6883F satellite repeat
is capable of facilitating recruitment of the MSL complex to nearby autosomal
genes, leading to functional dosage compensation. This suggests that the
presence of 1.6883F, and possibly other 1.688X repeats on the X chromosome,
contribute to its distinctive identity.
Recruitment and spreading of the MSL complex at autosomal transgenes
A roX1 transgene inserted on an autosome, in a roX1roX2 mutant
background, recruited the MSL complex to the autosomal integration site, and bidirectional, non-contiguous spreading of the MSL complex as well as H4K16
acetylation was observed (KELLEY et. al., 1999). This suggested an increase in
gene expression in the vicinity (KELLEY et. al., 1999). This was shown to be true
a couple years later, albeit with the use of a reporter system (HENRY et. al.,
2001).

Insertion of roX1 and/or roX2 transgenes on an autosome led to
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increased expression of an adjacent lacZ reporter gene, but a full two-fold
increase in expression was very rarely observed. This was attributed to
differences in local chromatin environment (HENRY et. al., 2001). It was later
demonstrated by microarray and RT-PCR analyses that the presence of an
autosomal roX transgene led to recruitment and spreading of the MSL complex in
the vicinity, leading to an almost two-fold increase in gene expression (PARK et.
al., 2010). Our findings in the current study are consistent with previous
observations. With wild type roX genes present on the X chromosome, we
observed that an autosomal transgene containing roX1 only recruited the MSL
complex to the autosome in the form of a sharp band, and spreading to
neighbouring polytene bands was not observed. However, when 1.6883F was
present on the transgene along with roX1, we observed consistent spreading to a
distal polytene band. This indicates that the repeats may enhance the spread of
the MSL complex. In the Park et. al. study, rescue of a haplo-insufficient
phenotype of the Minute gene was observed, but only in a roX-

mutant

background. While we also observed rescue of a haploinsufficient phenotype
with a transgene containing roX only, our system was, in fact, completely wild
type for the canonical dosage compensation machinery.
X-limited distribution of the satellite repeats
1.6883F is one of hundreds of similar repeats that are broadly distributed
on euchromatic portions of the X chromosome (KUHN et. al., 2012). They are
generally arranged in clusters of 1-4 units. Owing to the near-exclusive Xlocalization of a sub-family of these repeats, they have been postulated to act in
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dosage compensation (WARING and POLLACK, 1987; DIBARTOLOMIES et. al.,
1992). In D. melanogaster, chromosome-specific satellite repeats are strikingly
enriched on the X chromosome, accounting for 45 times more coverage than the
autosomes (GALLACH, 2014). This is also true for other Drosophilid species in
which the copy number, length and sequence of these repeats vary, but
enrichment on the X is conserved. Interestingly, the newly evolved X
chromosome arm in D. pseudoobscura rapidly acquired satellite repeats that are
also found on the ancestral X (GALLACH, 2014). The mechanism by which these
repeats proliferate is unknown, but our current study suggests a potential
mechanism that would restrict them to the X chromosome. As D. melanogaster
autosomal 1.688X repeats will cause misregulation of nearby genes in males, and
thus become targets of natural selection.
How do the 1.688X act in dosage compensation?
Previous studies have identified a single class of DNA elements as
instrumental in MSL recruitment. These are the MREs, a component of the CES.
The CES were identified based on their ability to recruit a core MSL complex
consisting of MSL1 and MSL2 (ALEKSEYENKO et. al., 2006). This recruitment is
based on the presence of the MRE motif, which is bound by the adaptor protein
CLAMP. How 1.6883F contributes to MSL recruitment is currently unknown. We
hypothesize that the CES and 1.688X function as independent elements that
facilitate X-identification and dosage compensation. While the MREs are present
genome-wide, they are modestly enriched on the X chromosome. In contrast,
1.688X are almost exclusive to the X chromosome. This combination of
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sequences may give the X chromosome a distinct identity. One hypothesis is that
1.688X and the siRNA pathway modulate the architecture of the X chromosome
(MENON et. al., 2014). Interestingly, the X chromosome assumes a distinct
nuclear domain in male fruitflies. Dosage compensated genes lie closer together
in the interphase male nucleus as compared to females (GRIMAUD and
BECKER, 2009). 1.688X flanking a puff at 2B have been implicated in the
distinctive architecture of the tip of the X chromosome (BENOS et. al., 2000).
Thus the DNA-motif based recruitment of the MSL complex by CESs and 1.688Xenabled nuclear domain formation would act in complementary ways to ensure
precise identification of the X chromosome. Parallel ideas have been proposed in
mammalian dosage compensation, wherein the LINE repetitive elements and
small RNA corresponding to them have been implicated in formation of a
silencing domain comprised of the inactive X chromosome (CHOW et. al., 2010).
The 1.688X repeats lend identity to the X chromosome
Previous studies demonstrated that ectopic expression of 1.6883F hpRNA
increases male survival in roX1roX2 mutant flies, indicating that 1.6883F may be
the source of the small RNA acting in dosage compensation (MENON et. al.,
2014).

Our current study complements these previous findings with a true

functional test of the cis regulatory role of 1.6883F DNA. Significantly, this study
was performed in flies that were completely wild type for the canonical dosage
compensation machinery comprised of the roX genes and MSL proteins. When a
transgene with 1.6883F is inserted on an autosome, recruitment and spreading of
the MSL complex induces increased gene expression in the vicinity of the
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transgene integration site. Increase in gene expression appears relatively
insensitive to distance from the transgene up to 142 Kb, but is enhanced by
elevated basal gene expression. This was unsurprising considering the X
chromosome has only two roX genes and the 1.688X are non-uniformly
distributed along its length. Moreover, the transgene bearing only 1.6883F also
leads to a partial rescue of lethality associated with hemizygosity of the
autosomal region. Rescue is enhanced by expression of hpRNA from 1.6883F,
but this depends on 1.6883F inserted on the autosome. This is consistent with
siRNA acting at cognate targets that are broadly but exclusively distributed on
the X. Thus we have shown that the 1.6883F repeats identify the X chromosome
and distinguish it from autosomes.
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CHAPTER 4 AN INVESTIGATION OF THE ROLE OF THE 1.6884A REPEAT
LOCUS IN DROSOPHILA MELANOGASTER DOSAGE COMPENSATION
The studies described in this chapter were completed with Lisa Spencer,
an undergraduate student. This was a part of her Undergraduate Honors Project.
INTRODUCTION
The discovery that the siRNA pathway modulates X-chromosome
recognition and dosage compensation in Drosophila melanogaster was
fascinating and led to many questions (MENON and MELLER, 2009). One of
these was the source of the small RNA. The X chromosome of Drosophila
melanogaster is enriched for a family of euchromatic satellite-related repeats
called 1.688X (WARING and POLLACK, 1987; DIBARTOLOMIES et. al., 1991).
Our lab discovered that when hairpin RNA (hpRNA) was expressed from the
1.688X repeat at the 3F cytological position (called 1.6883F), it led to the
production of siRNA, partially restored MSL complex localization to the X
chromosome and partially rescued lethality in roX1roX2 mutant males (MENON
et. al., 2014). However, expression of hpRNA from repeats at 1.6881A and
1.6883C, which share 89% and 68% sequence identity to 1.6883F, did not rescue
roX1roX2 mutant males. This unexpected specificity prompted us to further
explore the roles of individual repeat clusters in dosage compensation.
The most similar repeat cluster to 1.6883F is 1.6884A. These two repeats
share 94% sequence identity. 1.6884A is close to 1.6883F on the X chromosome,
and these repeats flank roX1 (Fig.4.1, top). The sequence similarity prompted the
idea that 1.6884A may play a redundant role with 1.6883F in generation of siRNA
that is active in dosage compensation. The spatial proximity and flanking of roX1
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may also reflect a shared function, such as delineation of a chromatin domain
containing roX1. Therefore we decided to generate a simultaneous deletion of
both repeat clusters and test the effect on dosage compensation.
1.6883F and 1.6884A are closely situated in the genome (~210Kb apart),
and it would be extremely challenging to recombine two separate mutations to
generate a double knockout. Therefore, we chose to use the CRISPR-Cas9
system to delete 1.6884A in a fly strain that already lacks 1.6883F. This strain is yw
roX1VM18A, which lacks part of the roX1 gene, the complete 1.6883F repeat cluster
and part of echinus (ec), distal to 1.6883F (Fig. 4.1). The CRISPR-Cas9 system,
although a relatively newly developed technique, has been widely used for
targeted, efficient mutagenesis in Drosophila melanogaster (BASSETT and LIU,
2014).
MATERIALS AND METHODS
Fly culture and genetics:
Flies were maintained at 25°C on standard cornmeal-agar fly food. The yw
roX1VM18A mutation, a 15.4 Kb deletion that removes 1.6883F and mutates ec and
roX1, has been previously described (DENG et. al., 2005). The X chromosome
balancer Binsincy has been described (LINDSLEY and ZIMM, 1992), and
information about a w+mC-marked X chromosome insertion at 4A4 (stock #
13524) can be found at flybase.org.
Cloning of chimeric RNA (chiRNA) constructs:
Oligos complimentary to the genomic sequence flanking 1.6884A were
designed based on guidelines found at http://flycrispr.molbio.wisc.edu/ (Oligo and
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primer sequences are presented in Table 4.1). Briefly, each oligo sequence
selected was 19 nt long and flanked by an NGG PAM sequence. Sense and
antisense oligos were designed with overhangs complimentary to those
generated by the BbsI enzyme, and annealed to each other. The annealed oligos
were ligated into the pU6-BbsI-chiRNA vector that had been digested with BbsI
(WAKIYAMA et. al., 2005). We designed two primers, pU6_fwd and pU6_rev,
flanking the BbsI site in pU6-BbsI-chiRNA. One of these primers and one of the
oligos were used for colony PCR to identify positive clones. The positive colonies
were tested for the presence of the insert by performing restriction digestions
using BbsI. The BbsI site is destroyed during cloning, so correctly made
constructs remained uncut by BbsI. Sequencing using PU6_fwd and PU6_rev
was also used for confirmation (Applied Genomics Technology Center). Four
CRISPR constructs were generated - DO1 and DO2 target sites immediately
distal to 1.6884A, while PO1 and PO2 target sites immediately proximal to
1.6884A.
Injection and detection of flies having deletions:
Four mixtures of plasmids, each containing one proximal and one distal
CRISPR construct; along with a Cas9 enzyme source were injected into yw
roX1VM18A embryos by Rainbow Transgenic Flies Inc. (Camarillo, CA). Injected
flies were mated to the Binsincy balancer; or to P{SUPor-P}KG04506, a w+mCmarked insertion at 4A4 (stock # 13524) used to track inheritance of the mutated,
unmarked X chromosome. F1 offspring were mated to Binsincy or P{SUPorP}KG04506 and stocks homozygous for a single mutated X chromosome were
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established (Figs. 4.2 & 4.3 for mating strategy). After ~5 days, the F1 flies were
removed from the cross and single fly PCR was performed using the primers
DP2_fwd and PP1_rev, which flank the chiRNA target sites. In wild type flies,
DP2_fwd and PP1_rev amplify an ~1150 bp product, which is rarely obtained due
to its size. Successful deletion of 1.6884A is detected by the reduction in size of
this amplicon to ~150 bp. Two additional flanking primers (DP1_fwd and
PP2_rev) were also generated, but did not produce a consistently strong PCR
product. The primers CT-Pep(F) and CT-Pep(R) produce a 550 bp amplicon
used for template control PCR. All PCR reactions were run on the Bio-Rad
S1000 thermal cycler on the program SJLONG50 (1= 95°C for 5:00; 2= 95°C for
0:30; 3= 50°C for 0:30; 4= 72°C for 2:30; 5= GOTO 2, 28 times; 6= 72°C for
10:00; 7= 4°C FOREVER; 8= END).

1.6883F
1.6884A

1.6881A
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1 Mb

20 Kb
ec

1.6884A

1.6883F
roX1

DP2_fwd

1.6884A

PO2

PO1

DO1

DO2

roX1VM18A

100 bp

PP1_rev

Fig. 4.1. Location of 1.6884A and CRISPR-Cas9 strategy used for deletion of
1.6884A. The top panel shows the X chromosome with the centromere (black
circle) on the right. The positions of three satellite repeats are indicated. The
middle panel expands the 3F-4A region to illustrate the proximity of 1.6883F and
1.6884A to one another and to roX1. The mutation roX1VM18A is deleted for 15.4
Kb (black bar). The bottom panel expands 4A4, illustrating positions of the oligos
used for generation of chiRNA constructs and primers used to detect deletions.
1.6884A, in an intergenic region, is 4.5 Kb from the nearest annotated gene
(CG43689).
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Primer / Oligo name

Sequence

PO1_sense

CTTCGATTATGCCCGAATGTTGTT

PO1_antisense

AAACAACAACATTCGGGCATAATC

PO2_sense

CTTCGGCAAAGCGGACAAACTAAT

PO2_antisense

AAACATTAGTTTGTCCGCTTTGCC

DO1_sense

CTTCGTTGGCACTCAGTTAATCTTA

DO1_antisense

AAACTAAGATTAACTGAGTGCCAAC

DO2_sense

CTTCGGAGATTTCATAGGCCAGTT

DO2_antisense

AAACAACTGGCCTATGAAATCTCC

PU6_fwd

AGGGTTCTTAAGACCATTTGCC

PU6_rev

GCACCGACTCGGTGCCAC

DP1_fwd

AAGCCAAACAGCCGGTGTGTCC

DP2_fwd

TTGAAAAAGTCTCGTAGGACGC

PP1_rev

GAGTCTCTGCATGTGGATCCG

PP2_rev

ACTGGGATTTGGGCCACCATGG

CT-Pep(F)

CATGCCATGGTCGGCCCGTCTTTCAG

CT-Pep(R)

CCGCTCGAGCGTGTGCCATCTTTCTG

Table 4.1. Sequences of oligos used for generation of CRISPR chiRNA
constructs and primers used for PCR.
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F0

X

Binsincy

Y

P{SUPor-P}KG04506
Discard male offspring

F1

X*

Binsincy

X*

P{SUPor-P}KG04506

Y

X*

&
X*

Binsincy

X*

Binsincy

Y

X*

Fig. 4.2. Mating strategy for injected males. Injected male flies (F0) produce
offspring with potential deletions of 1.6884A on the X chromosome. F0 males
were mated to Binsincy / P{SUPor-P}KG04506 virgins. All male offspring were
discarded. Female offspring (F1) with the potential deletion (indicated by *) over
either of the marked chromosomes were collected. Individual virgins were mated
to Binsincy males, and homozygous stocks generated. After 5 days, the F1
females were removed and subjected to single fly PCR for detection of
mutations.
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F0

F1

X

Binsincy

X

Y

X*

Binsincy

X*

Binsincy

Y

X*

&
X*
Y

Binsincy
P{SUPor-P}KG04506

X*
X*

Fig. 4.3. Mating strategy for injected females. Injected female flies (F0)
produce offspring with a potential deletion of 1.6884A on the X chromosome
(indicated by *). F0 females were mated to Binsincy males. F1 X*/ Binsincy
virgins were mated singly to Binsincy males, to enable generation of X*/ X*
stocks. F1 X*/Y males were singly mated to Binsincy / P{SUPor-P}KG04506
virgins, and offspring mated to produce X*/ X* stocks. After 5 days in the vial, F1
flies were removed and subjected to single fly PCR for detection of mutations.
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RESULTS
The pU6-BbsI-chiRNA vector enables generation of a chiRNA that targets
the Cas9 nuclease enzyme to a homologous region of the genome (WAKIYAMA
et. al., 2005). Constructs for two chiRNAs on each side of the 4A repeat cluster,
DO1 and DO2 (Distal Oligo 1&2, distal to 1.6884A), and PO1 and PO2 (Proximal
Oligo 1&2, proximal to 1.6884A) were made (Fig. 4.1, Table 4.1). From these we
assembled four combinations of chiRNA constructs, (DO1+PO1, DO1+PO2,
DO2+PO1 and DO2+PO2) which were sent for injection (Table 4.2). Our
expectation was that simultaneous cuts on the proximal and distal sides of
1.6884A would be repaired by Non-Homologous End Joining (NHEJ) to delete a 1
Kb region. To screen for deletions we generated two primers, DP2_fwd on the
distal side and PP1_rev on the proximal side of 1.6884A; such that a PCR product
of ~1150 bp is obtained from a wild type fly squash. On deletion of 1.6884A we
expected a PCR product of ~150 bp. Partial deletions, such as a single break
repaired by NHEJ would yield PCR products of intermediate size. This would
occur if only one of the chiRNAs introduced a break.
We observed PCR products of intermediate size with a relatively high
frequency. 16.77% of examined F1 offspring yielded a PCR product larger than
150 bp but smaller than 1150 bp, indicating a single cut that produced a small
deletion (Table 4.2). Different combinations of chiRNAs yielded these mutations
with differing efficiencies (Table 4.2). In contrast, only a single injected fly yielded
a PCR product of ~150 bp, indicating complete deletion of the 1.6884A repeat
cluster (0.4% of offspring, Fig. 4.4A, Table 4.2). This was a female offspring (F9)
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of a male (P1D2M10) injected with PO1 and DO2. Sequencing of the 150 bp
PCR product revealed breakpoints adjacent to the chiRNA target sites (Fig.
4.4B). The deleted female (P1D2M10-F9) was mated to Binsincy males, and the
offspring mated with one another to generate a homozygous stock of
roX1VM18A1.6884AΔ (Fig. 4.2).
When dosage compensation is perturbed, the male to female ratio is
reduced. The survival of males with the roX1VM18A1.6884AΔ X chromosome was
tested to determine if simultaneous deletion of 1.6883F and 1.6884A affects
dosage compensation. The male/female ratio was 0.92, indicating no
perturbation of dosage compensation. Next, we tested the role of the
simultaneous deletion of 1.6883F and 1.6884A in a sensitized genetic background.
Drosophila melanogaster females do not normally dosage compensate, but can
be forced to do so by expression of MSL2 from the [w+hsp83-M2]6I transgene.
This leads to reduced female survival, with a female/male ratio of 0.366.
Mutations affecting the dosage compensation machinery are expected to
improve the survival of these females. However, roX1VM18A1.6884AΔ; [w+hsp83M2]6I/+ flies display a female/male ratio of 0.207. Thus no conclusion can be
drawn about the role 1.6884A in dosage compensation.
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chiRNA

Injected flies

Number of

Partial

Complete

construct

mated (F0)

offspring

deletions

deletions

tested (F1)

detected

detected

pair
PO1+DO1

38

163

19.02% (31)

-

PO1+DO2

28

142

15.49% (22)

1.41% (2)

PO2+DO1

11

91

23.08% (21)

-

PO2+DO2

15

99

9.09% (9)

-

Total

92

495

16.77% (83)

0.4% (2)

Table 4.2. Number of flies screened and partial and complete deletions
obtained using the various chiRNA construct combinations. Number of
offspring with deletions is indicated in parentheses.
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A

MW
BP
1000
500
151 bp
100

B
P1D2M10-F9
CTCTGGGACG --------------------------------------------------------------CTCTTGGG!
CTCTGGGACGGGACACCGAACTGGCCTATGAATCTCCGTG//GTGCGATTATGCCCGAATGTTGTTCGGTGTACTCTTGGG!
DO2

PO1

Reference genome

Fig. 4.4. Molecular characterization of 1.6884AΔ. (A) Identification of the
1.6884A deletion using PCR. Amplification of a P1D2M10-F9 fly squash with the
primers DP2_fwd and PP1_rev produces a product of 151 bp (right lane). (B)
Confirmation of 1.6884AΔ by sequencing. The amplicon shown in (A) was
sequenced (top) and aligned to the reference genome (bottom). Breakpoints are
adjacent to DO2 and PO1 (underlined in the reference genome), the combination
of chiRNA plasmids injected into P1D2M10.
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DISCUSSION
The X chromosomes of several Drosophilid species are enriched in
repetitive sequences (GALLACH, 2014). This has led to speculation that these
sequences function in X-chromosome specific phenomena, such as dosage
compensation. A previous study revealed that siRNA from 1.6883F, but not from
the similar repeats 1.6881A and 1.6883C, was biologically active in dosage
compensation (MENON et. al., 2014). The goal of this present study was to
determine if the highly similar satellite repeat clusters 1.6883F and 1.6884A are
redundant for generation of siRNA that participates in Drosophila melanogaster
dosage compensation. We used the CRISPR/Cas9 system to generate the
1.6884A deletion in a fly strain lacking 1.6883F. This double mutant allowed us to
test the idea that two highly similar repeats at 3F and 4A were redundant in
function.
roX1VM18A1.6884AΔ flies, deleted for both 1.6883F and 1.6884A repeat
clusters, do not display an obvious male phenotype. Moreover, in the sensitized
genetic background of induced dosage compensation in females, the
roX1VM18A1.6884AΔ chromosome did not lead to increased female survival.
However, these results do not rule out a function for the 1.6884A cluster in
production of dosage compensation specific siRNA. Previous studies involving
the role of the siRNA pathway were performed in a highly sensitive roX1roX2
mutant background. To perform tests in a similar genetic background would
involve recombining the roX1VM18A1.6884AΔ X chromosome with a roX2 mutation.
This might enable detection of the effect of the 1.6884A cluster on dosage
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compensation. An alternative possibility is that only the 1.6883F repeat cluster
produces biologically active siRNA, but many 1.688X repeats are targets of this
siRNA and serve to enhance recruitment to nearby genes. Precise deletion of
1.6884A enables us to test ideas about how these repeats influence nearby
genes.
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CHAPTER 5 SUMMARY AND PERSPECTIVES
The unique distribution of the 1.688X satellite repeats on the X
chromosome suggested that these repeats might act to identify X-chromatin.
Therefore, I decided to test the function of 1.688X as cis-acting elements in an
autosomal dosage compensation system. I discovered that, in addition to roX1containing transgenes, a transgene containing 1.6883F only could recruit the MSL
complex to the autosome, leading to upregulation of genes in the vicinity and
functional dosage compensation. Ectopic expression of hpRNA from the 1.6883F
sequence further enhanced autosomal compensation, but only when 1.6883F was
present in the autosomal transgene (Chapter 3). These findings strongly suggest
that the 1.688X sequences are targets of an siRNA-dependent mechanism that
identifies the X chromosome. The mechanism by which 1.6883F, and possibly
other 1.688X repeats, act in dosage compensation is not known. Some
interesting questions raised and possibilities are discussed below.
Do other 1.688X repeat clusters recruit dosage compensation to an
autosome?
The hundreds of 1.688X clusters on the X chromosome share an average
of 73% similarity (KUHN et. al., 2012). If the mechanism by which these
sequences act in dosage compensation involves recruitment of chromatin
modifiers at cognate loci, then 1.688X repeats besides 1.6883F would also be
expected to be targets of such modifiers, and to recruit dosage compensation in
cis. 1.6881A and 1.6883C share 89% and 68% sequence identity respectively with
1.6883F. Therefore, it would be interesting to know if they act as cis regulatory

79
sequences. The [>roX1> w+mC>1.6883F >] transgene is designed such that
1.6883F can be easily replaced with any other candidate sequence that we wish
to test. Transgenes bearing 1.6881A and 1.6883C could be tested to see if they
recruit the MSL complex to the autosome or enhance the recovery of male larvae
carrying a lethal deficiency on the homologous autosome. If recruitment of
compensation in cis is a general property of 1.688X repeats, it would be
interesting to test for enhancement of this effect with 1.6883F siRNA. 1.6883F is in
very close proximity to roX1 on the X chromosome; and roX1 is responsible for
initiation of dosage compensation as it is transcribed several hours before roX2
(MELLER, 2003). On account of its close spatial proximity to roX1, 1.6883F may
also be expressed very early, and this may enable generation of siRNA that
participates in X-identification. Close spatial proximity of two important
components of the dosage compensation machinery would enable co-operative
function, thus forming a “Locus Control Region” for the entire X chromosome.
Are specialized chromatin modifications observed at 1.688X?
The mechanism by which the siRNA pathway and 1.688X contribute to
dosage compensation remains elusive. Components of the siRNA pathway have
previously been implicated in targeting of chromatin modifications and
heterochromatin formation in somatic tissues of Drosophila melanogaster
(FAGEGALTIER et. al., 2009; CERNILOGAR et. al., 2011). It is possible that a
similar phenomenon occurs at the dosage compensated X chromosome of male
fruit flies, where siRNA originating from one or more 1.688X clusters maybe
targeting chromatin modifications to cognate loci. Chromatin Immunoprecipitation
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studies at the 1.688X repeats and surrounding loci could be used to test for
enrichment of specific histone marks at the 1.688X compared to neighboring
regions. Additionally, the presence of these same histone marks could be tested
at the autosomal site of the [1.6883F] transgene. If such distinct chromatin marks
are identified, then it will be interesting to see if knockdown of the RNAi pathway
components, especially Ago2, disrupts these chromatin marks at the autosomal
transgene. Identification of distinct chromatin marks will be a worthwhile path to
follow because we hypothesize that these marks alter the properties of chromatin
to enable the MSL complex to more easily enter or spread along the X
chromosome.
Is nuclear architecture involved in 1.6883F-based rescue?
The dosage compensated X chromosome has been postulated to form a
male-specific conformation in the interphase nucleus, such that compensated loci
lie closer together in interphase male nuclei (GRIMAUD and BECKER, 2009). It
is possible that the 1.688X satellite repeats form long-range associations that
may enable the X chromosome to form a specific conformation/nuclear domain
(MENON and MELLER, 2015). It might be extremely productive to perform
Chromosome Conformation Capture (3C), and look for associations between
distant 1.688X satellite repeats. If long range interactions between 1.688X repeats
do exist, then the rescue of dosage compensation by the autosomal [1.6883F]
transgene could be a consequence of the autosomal region looping into or near
the X chromosome territory via formation of long-range associations. The X
territory is enriched for the MSL complex, which could move into nearby
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transcribed genes, even if these genes are on an autosome. 3C studies between
the autosomal transgene and X-linked loci could be performed to test this
hypothesis. A parallel mechanism has been proposed in mammalian dosage
compensation, where Long Interspersed Nuclear Elements (LINEs) and small
RNAs originating from LINEs participate in the formation of a silent domain
comprised of the inactive X chromosome (CHAUMEIL et. al., 2006; CHOW et.
al., 2010). Moreover, the long, non-coding Xist RNA has been shown to spread
on and silence the inactive X chromosome by exploiting the existing threedimensional conformation of the X (ENGREITZ et. al., 2013).
Do additional trans-acting factors bind 1.688X or contribute to Xidentification?
If siRNA-dependent chromatin modifications at 1.688X are responsible for
their mode of action in dosage compensation, then additional trans-acting
proteins are very likely to be involved in the pathway. Drosophila protein 1 (D1) is
a non-histone, chromosomal protein that binds AT-rich satellite repeats in
Drosophila, and has been specifically shown to bind the 1.688g/cm3 family of
repeats (LEVINGER and VARSHAVSKY, 1982). Co-incidentally, it shares
features with the mammalian HMGA proteins that are known to induce structural
changes in chromatin substrates (REEVES and BECKERBAUER, 2001;
WEILER and CHATTERJEE, 2009). Another candidate protein for binding at the
1.688X repeats is the chromodomain-containing Heterochromatin Protein 1
(HP1), which recognizes and binds trimethylated Histone 3 Lysine 9
(BANNISTER et. al., 2001). The finding that HP1 binding is significantly elevated
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on the X chromosome compared to autosomes, in male but not female flies is
provocative (DE WIT et. al., 2005). ChIP and knockdown studies could be
performed in the future to test if these proteins are enriched at 1.688X repeats,
and if they mediate the function of 1.688X sequences in Drosophila melanogaster
dosage compensation.
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APPENDIX A CONFIRMATION OF TRANSGENE INTEGRATIONS BY IN-SITU
HYBRIDIZATION
The transgene [roX1+1.6883F] was site-specifically integrated at three
cytological positions – 22A3, 24A2 and 25C7 (Chapter 3). The individual
integrations were then sequentially recombined to obtain a line with three
integrations of the transgene. Recombinants were identified by dark red eye color
and confirmed by in-situ hybridization. In-situ hybridization was performed to
salivary

gland

polytene

chromosomes

from

larvae

homozygous

for

[roX1+1.6883F]22A3+24A2+25C7. A probe for 1.6883F was used and the protocol was
performed as described (MENON et. al., 2014). Three signals were observed
from the tip of chromosome 2L at the expected positions (Fig. A1), and thus I
could confirm that I had generated a line with three integrations.
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Fig. A1. Confirmation of a recombinant chromosome with three copies of
the complete transgene. In-situ hybridization was performed using a probe to
1.6883F. The black arrow marks the 2L telomere. Distinct signals corresponding
to three transgene integration sites are observed.
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APPENDIX B VERIFICATION OF TRANSGENE EXCISIONS BY PCR
FRT and LoxP sites were included on [roX1+1.6883F] to enable excision of
roX1 and 1.6883F, by expression of FLP and Cre recombinase, respectively. Loss
of w+mC and resultant white eye color enabled detection of excisions (Chapter 3).
PCR was used for molecular confirmation of excision events using primers
specific to sequences within roX1 and 1.6883F (Fig.B1 for schematic, Table B1
for primers). A genomic template from a fly having the complete [roX1+1.6883F]
transgene produced amplicons with all primer pairs. A primer pair specific to roX1
did not amplify when genomic DNA from a fly with a [1.6883F] transgene was the
template, but did amplify when the [roX1] transgene was present. Similarly, when
a primer pair specific to 1.6883F was used for PCR, amplicons were detected
from a fly containing the [1.6883F] transgene but were not detected when the
[roX1] transgene was present (Fig. B2).
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Fig. B1. Schematic showing the SJTG clone and primers. The SJTG clone
was used for generation of [roX1+1.6883F] transgene integrations. Primer names
and sequences are presented in Table B1.
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No. in

Primer name

Primer sequence

Fig. B1
-

roX1F1264

CATACCTCTATCGGATGCATGTGGCG

-

roX11490R

TACACTCGAGTCGATGCGTCGTTTATTG

1

BPR08wh(F)

TAGCTCCTGATCCTCTTG

2

Sat_Frt_F

GACTGCAGCGGCCGCTTCCGAAGTTCCTATTCTC

4

roX1HincIIR

CTCAATAGCATAAAAAATAGTTGACC

5

Sat_LoxP_F

ATCGTTCGGCCGTCGACTTAATATAACTTCGTATAATGTA

6

attB_210R

TGACCGTCGAGAACCCGCTGACG

8

BPR26

GAGGTCTAGACCCACCAAAGAGGCTTGACAGAAGA

9

roX1R_706

TCATATCCACTAGCATAAGGCTGGCG

10

roX1_LoxP_F

ATCGGTCGGCGGCCGCGCGCTTAATATAACTTCGTATAA
TGTA

Table B1. Primers used for confirmation of Cre and FLP-based excisions

A

B

C

[1.6883F]

[roX1]

[roX1+1.6883F]

yw
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roX1F1264
+
roX11490R

roX1HincIIR
+
Sat_LoxP_F

Primer pair
used

roX1R_706
+
roX1_LoxP_F

Fig. B2. Verification of excisions of the [roX1+1.6883F] transgene. (A)
Amplification can be detected from all templates in a control PCR reaction. (B)
When primers specific to 1.6883F were used, a product cannot be detected in a
squash from a fly that had the excised [roX1] transgene. (C) Similarly, a squash
from a fly with the excised [1.6883F] transgene does not amplify with primers
specific to roX1.
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APPENDIX C LIST OF PRIMERS FLANKING TRANSGENE INTEGRATION
SITES ON 2L
Integration

Primer

site

name

VK00037
Su(Hw)attP6

P{Cary}attP40

Primer sequence

Proximity to
insertion site

22A3_F1

GAATATCTGTTCATTAGACTG

22A3_R1

CACCGCGCCGGGTAAAAAGCACATGGG

24A2_L1

GGGTATTTTCGCTCTCCCAGAC

24A2_L2

CCAAGCTTATATGGTCTCAGATC

25C7_F1

CGGATTTTCGACCACATCACTCC

25C7_F2

GTCTAGGGAACCGTTGACCTTG

25C7_R1

GCGAGAATTCGGGGGCTTTCGGTG

25C7_R2

CCAACCGGAGATTATCTCACGCAG

Distal
Proximal
Proximal

Distal

Proximal
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APPENDIX D GENERATION AND CHARACTERIZATION OF INTERNAL
DEFICIENCIES ON 2L
After two initial failed attempts to generate large, lethal deficiencies on the
tip of 2L that could be rescued by autosomal dosage compensation, I decided to
generate smaller nested deficiencies on 2L. The expectation was that smaller
deficiencies would be easier to obtain and maintain. Even if these are not
completely lethal, other phenotypes, such as partial lethality or infertility, could be
tested for rescue. Moreover, the nested internal deficiencies could be positioned
such that they were closer to existing transgene integrations and might be
rescued better.
I selected P-elements carrying an FRT site marked with w+mC at different
positions on 2L. The matings were set up such that the FRT sites on the two Pelements were in the proper orientation for recombination. Upon expression of
FLP, if recombination occurred, an internal deficiency was generated and the
w+mC was lost from both P-elements. Flies with these deletions were thus
identified by white eyes (See Fig. D1 for schematic, Table D1 for positions of Pelements and stock numbers). The deficiencies were recovered over a
duplication of the 2nd chromosome, Dp(2;2)Cam1 (stock # 3392). The duplication
spans from cytological positions 21E2 to 23D2, the region of the chromosome
containing the expected deficiencies. Occasionally, instead of Dp(2;2)Cam1, we
used Dp(2;Y) 22A2 (Chapter 2) to obtain males with internal 2L deficiencies over
a second chromosome balancer such as CyO or In(2L2R)Bcg.
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P{XP}
w

FLP

w

CyO

Dp (2:2)

Pbac{RB}

Deficiency balanced by duplication
white eyes

Fig. D1. Schematic showing strategy for generation of internal deficiencies
on 2L. Dysgenic flies were generated carrying P-elements with FRT sites on
both 2nd chromosomes and a source of FLP on the 3rd chromosome. These were
mated to flies with the Dp(2;2)Cam1 / CyO. The dysgenic parent had red eyes.
Offpsring with the expected deficiency were white-eyed and had straight wings.
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Several internal deficiencies were generated and named based on their
size in Mb, for example a deficiency of 0.64 Mb was called Internal Deficiency
0.64 (ID0.64). PCR was performed using a primer in the P-element and a primer
in the flanking genomic DNA (Table D2 for list of primers). All white-eyed flies
that produced an amplicon corresponding to at least one of the P-element ends
involved in the recombination thus had the deficiency. Polytene squashes were
used for confirmation of the deficiency. In a squash from a male third instar larva
having ID1.07, the homolog can be seen unapired and looped out in the region of
the deficiency (black arrow, Fig. D2). Deletions extending over more than one
cytological division, 0.8-1.5 MB (median 1.1Mb) are generally lethal (STENBERG
et. al., 2009). In accord with this, most of the internal deficiencies I generated
were completely viable and could not be used (Table D1).
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Name of

Size of

Deficiency

Deficiency

Proximal end

Distal end

Lethal

(Position & Stock #) (Position & Stock #)

(Y / N)

22E1

22B2

No

(18037)

(d05547)

22A1

21D1

(18673)

(d05169)

22A2

21D1

(18757)

(d05169)

22B1

21D1

(17972)

(d05169)

22B2

21D1

(18871)

(d05169)

23D2

22B2

(18639)

(d05547)

24F4

23C4

(19264)

(18110)

23E4

22B2

(18643)

(d05547)

23F1

22B2

(18957)

(d05547)

(Mb)
ID0.64
ID0.88
ID1.07
ID1.25
ID1.27
ID1.39
ID1.4
ID1.59
ID1.63

0.64
0.88
1.07
1.25
1.27
1.39
1.4
1.59
1.63

No
No
No
No
Yes
No
Yes
Yes

Table D1. List of internal deficiencies generated on chromosome 2L. The
size of the deficiency is indicated in Mb, and the stock numbers are shown in
parentheses. Only three deficiencies (all >1.3 Mb) were lethal.
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Position of

Stock

P-element

number

21D1

22B2
22E1
23C4
23D2

23E4
24F4

d05169

d05547
18037
18110
18639

18643
19264

Primer name

Primer sequence

21D1_dist1

CCCTCCTAGGACACGGGT

21D1_dist2

GGGAGCATTGCCAGGCCCAAG

22B2_dist1

CAACTTGCTACTTGACTCGAC

22B2_dist2

CCACGCAACGATCGTTAGCG

22E1_prox1

CGCCATTTGGAACCGTACAAG

22E1_prox2

GTACTACCCGGCTTATTTAACC

18110_F1

TTCAGAAGAACGTGAGTCGGGTATCAC

18110_F2

GTACAACCACTGGATAACCTAATTTCGGC

23D2_prox1

CGCCGATGAACCCATTCCAAAG

23D2_prox2

GGCTTCAGAAGTCCCTTGG

23E4_prox1

CCGCCAAGTAGGTGGTCACAC

23E4_prox2

GCATGAGTATCCTCCTTCCGTAC

19264_R1

CATCTTTGGGCGCGGGGTCCAC

19264_R2

CAGTTTCTCTCTGTGTATAGTTAGGGCC

Table D2. List of primers used in molecular characterization of internal
deficiencies.

95

Fig. D2. Cytological characterization of ID1.07. ID1.07 is an internal deficiency
spanning from 21D1 to 22A2. The black arrow shows 2L, where a break can be
seen on one homolog and the other homolog is unpaired and looped out.
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While ID1.63 is a lethal deficiency, I did obtain a few heterozygous
escaper males. On mating these escapers to virgins, no embryos were observed
in the vial, thus indicating that the males were infertile. Upon closer examination,
I noticed genital malformations in these males (Fig. D3, panel A). I set up crosses
to recover males with ID1.63 over a homolog carrying three integrations of the
complete transgene [roX1+1.6883F]22A3+24A2+25C7, to see if male survival or the
infertility phenotype could be rescued. The number of males obtained from this
mating was similar to the number obtained with ID1.63 over a wild type homolog.
However, ID1.63 / [roX1+1.6883F]22A3+24A2+25C7 males were fertile. Thus the
infertility phenotype of ID1.63 / + was rescued by the transgenes (Table D3).
Moreover, ID1.63 / [roX1+1.6883F]22A3+24A2+25C7 males also had genitalia that
appeared normal (Fig. D3, panel B). This finding was very exciting, and I setup
several more matings with full and reduced transgenes, and with other
deficiencies of a similar size such as ID1.39 and ID1.63. However, I did not
recover a significant number of offspring, and these results could not be
replicated.
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A

B

ID1.63 / +

ID1.63 / [roX1+1.6883F] *3

C

+/+

Fig. D3. Genital malformation is rescued by [roX1+1.6883F] transgenes. (A)
An ID1.63 / + male shows genital malformations in the form of reduced terminal
structures (B) An ID1.63 / [roX1+1.6883F]22A3+24A2+25C7 male shows a wild type
rear end (C) A wild type male is pictured for reference.
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Transgene tested

Total number of

% Total

% fertile

males recovered (with

males with

males with

and without ID1.63)

ID1.63

ID1.63

None

394

1.5 (6)

0 (6)

[roX1+1.6883F]22A3+24A2+25C7

220

1.4 (3)

100 (3)

Table D3. Number of males recovered with ID1.63. Percentage of males with
ID1.63 is calculated as (males with ID1.63 / total number of males recovered)*
100. Percentage of fertile males with ID1.63 is calculated as (fertile males with
ID1.63 / total males with ID1.63)*100. Number of males is indicated in
parentheses in each case.
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APPENDIX E GENERATION OF LEXA OPERATOR ARRAYS
Introduction
The dosage compensated X chromosome forms a distinct threedimensional domain in the interphase nucleus (GRIMAUD and BECKER, 2009). I
wanted to test if roX1 or 1.6883F or both participate in the formation of this
domain. To do this, I decided to label the autosomal transgene with RFP (Red
Fluorescent Protein), and the X chromosome with GFP (Green Fluorescent
Protein), and then determine if the autosomal region containing the transgene is
recruited into or close to the X-specific nuclear domain by observing relative
localization of the green and red fluorescent spots. LexA is a bacterial DNAbinding protein that specifically recognizes and binds the LexA Operator
(LexAop) DNA sequence element (BRENT and PTASHNE 1984). I decided to
clone arrays of the LexAop sequence into the autosomal [roX1+1.6883F]
transgene, and generate flies carrying a LexA-RFP transgene, such that we
would be able to track the position of [roX1+1.6883F] in the interphase nucleus by
RFP localization.
Cloning of the LexAop arrays
The pSH18-34 vector that has 4 copies of the LexA operator, i.e. 8 binding
sites for the LexA protein (ESTOJAK et.al., 1995) was obtained from the
laboratory of Dr. Russell L. Finley, Jr. A SalI site present in the LexAop arrays in
pSH18-34 was destroyed by digestion with SalI, followed by a fill-in reaction
using T4 DNA Polymersae (NEB) and blunt end ligation. LexAop was amplified
from this modified pSH18-34 plasmid using the primers LexOp_F and LexOp_R,
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which contained XmaI sites (refer Table E1 for list of primers). The PCR product
was cloned into the pCR4-TOPO vector (Invitrogen). A linker (made by annealing
Amplink_top and Amplink_bot) was introduced into NotI and KpnI sites of
pBlueScript-SK vector such that it now had restriction sites in the following order:
SalI, XmaI, XhoI and BamHI. The LexAop unit was then excised from pCR4TOPO with XmaI and cloned into the XmaI site of the modified pBlueScript. This
plasmid was pBS-LexAop(1). T7 and T3 primers were used to identify inserts by
colony PCR. Restriction digestion and sequencing were used for confirmation.
pBS-LexAop(1) was then used in successive cycles of amplification by
restriction digestion with XhoI and BamHI to generate the vector that contains the
LexAop. pBS-LexAop(1) was also cut with SalI and BamHI to release the insert.
The SalI-BamHI insert was then ligated into the XhoI-BamHI cut vector (protocol
modified from ROBINETT et. al., 1996; see Fig. E1). Colony PCR was performed
after each step using T7 and T3 to identify clones that had arrays of a larger size.
Restriction mapping was used for confirmation. After 5 cycles of amplification, the
clone pBS-LexAop(5) with LexAop arrays of ~1600 bp was produced.
Expanding the arrays after this step proved extremely challenging. I
switched to CopyCutter™ EPI400™ Electrocompetent E. coli cells (Epicentre,
Illumina) to maintain clones at low-copy number. At this step, I switched to the
PCR program SJLONG50 for screening larger PCR products (parameters
described in chapter 4). This enabled generation of pBS-LexAop(6), with ~2100
bp of LexAop sequence. Although amplification was expected to be over 3 Kbp,
the size of arrays in pBS-LexAop(6) was much smaller than what was expected
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from a doubling of the array. This indicated that the repetitive sequence was
unstable.
As the array in pBS-LexAop(6) was of a sufficient size to enable
visualization with LexA-RFP, I decided to clone it into pUASTB. I digested pBSLexAop(6) using Sal, ligated it into pUASTB opened at XhoI and tried to
transform it into the CopyCutter™ EPI400™ cells. This cloning was attempted
several times, but was not successful.
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Fig. E1. Schematic for amplification of LexAop arrays. pBS-LexAoP(1) was
used in successive steps of restriction digestion and ligation to generate an array
of LexA operators. This strategy makes use of compatible cohesive ends
between SalI and XhoI and was modified from (ROBINETT et.al, 1996). pBSLexAoP(1) digested with XhoI+BamHI served as the vector. The same plasmid
digested with SalI+BamHI, generated the insert. During ligation, the compatible
cohesive ends of SalI and XhoI are ligated, destroying these sites and generating
pBS-LexAop(2), with 2 copies of the basic unit. This clone was then used for the
next amplification step, and the cycle was repeated. With each step in the
process, the amplification is expected to be exponential.
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Primer name

Primer sequence

LexOp_F

TCTCCCGGGCCATATCTAATCTTACCTCGAC

LexOp_R

GTCGAGGGATGATAATGCGCCCGGGCTC

Amplink_top

GGCCGCGTCGACCCGGGCTCGAGGATCGAGGATCCGTAC

Amplink_bot

GGATCCTCGATCCTCGAGCCCGGGTCGACGC

T7

TAATACGACTCACTATAGGG

T3

ATTAACCCTCACTAAAGGGA

Table E1. Primers used in cloning of LexAop arrays.
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APPENDIX F GENERATION OF TRANSGENIC FLIES HAVING A LEXA-RFP
TRANSGENE
In order to label an array of LexA operator sites with RFP (Appendix E), I
needed to generate transgenic flies that express a LexA- RFP fusion protein.
Genomic DNA from flies containing the RFP gene was used as a template to
amplify the RFP fragment with the primers RFP_F and RFP_R. These primers
introduce XhoI and XbaI sites, respectively (Table F1 for primer sequences). The
PCR product (~800 bp) was cloned into the pCR4-TOPO vector (Invitrogen), to
generate RFP-Topo. The LexA sequence (~700 bp) was amplified from the
plasmid pNLex-NLS using the primers LexA_NLS_F and LexA_NLS_R. The
primers introduce EcoRI and XhoI sites, respectively. A Nuclear Localization
Signal (NLS) is included in the amplicon. This was also cloned into pCR4-TOPO
to generate LexA-Topo. EcoRI and XhoI were used to excise the LexA-NLS
fragment, which was cloned into pUAST (BRAND and PERRIMON, 1993) to
generate pUAST_LexA. XhoI and XbaI were then used to excise RFP from RFPTopo, and the fragment was cloned into the pUAST_LexA vector to generate
pLexA+RFP. The primers pUAST_Hsp70Prom and pUAST_SV40Ter in the
pUAST vector flanking the MCS were used for screening clones by colony PCR.
Restriction digestion and sequencing were used for confirmation. pLexA+RFP
was injected into yw flies by Rainbow Transgenic Flies Inc. (Camarillo, CA). The
injected flies were screened by eye color and homozygous stocks were set up
(Table F2 for list of stocks).
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Primer name

Primer sequence

RFP_F

CCGCTCGAGGTCGCCACCATGAGGTCTTCC

RFP_R

GCCTCTAGAGAATTCGATGGCCGCTAAAGG

LexA_NLS_F

GCCGAATTCGCATACAATCAACTCCAAGCTTG

LEXA_NLS_R

GGACTCGAGGATCCCCGGGAATTCCAC

pUAST_ Hsp70Prom

AATCTGCAGTAAAGTGCAAG

PUAST_ SV40Ter

TAAAGGCATTCCACCACTGC

Table F1. List of primers used in generation of a LexA-RFP transgene.
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Name of stock

Chromosome

P{LexA-RFP w+} 19A2

X

P{LexA-RFP w+} 19A5

X

P{LexA-RFP w+} 59C

X

P{LexA-RFP w+} 59D

X

P{LexA-RFP w+} 86A

X

P{LexA-RFP w+} 9B

2

P{LexA-RFP w+} 23A

2

P{LexA-RFP w+} 27A

2

P{LexA-RFP w+} 27B

2

P{LexA-RFP w+} 56A

2

P{LexA-RFP w+} 13D

3

P{LexA-RFP w+} 19B

3

P{LexA-RFP w+} 22C

3

P{LexA-RFP w+} 23B

3

P{LexA-RFP w+} 91D

3

Table F2. List of transgenic fly stocks having a LexA-RFP transgene on the
indicated chromosome.
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ABSTRACT
A NOVEL ROLE FOR REPETITIVE SEQUENCES IN RECOGNITION OF THE
DROSOPHILA MELANOGASTER X CHROMOSOME
by
SONAL SURESH JOSHI
August 2016
Advisor: Dr. Victoria H. Meller
Major: Biological Sciences
Degree: Doctor of Philosophy
In humans and fruit flies, males have one X chromosome while females
have two. This imbalance in gene dosage is potentially lethal, and the process of
dosage compensation corrects it. The MSL (Male Specific Lethal) complex,
which is composed of five proteins and one of two functionally redundant long
non-coding roX (RNA on the X) RNAs, brings about dosage compensation in
Drosophila melanogaster. In fruit fly dosage compensation, all the genes on the
single male X chromosome are upregulated approximately twofold, via chromatin
modifications, to equalize gene dosage with the two X chromosomes of females.
This process calls for highly selective identification of the X chromosome in the
nucleus. The current model for X-recognition does not explain how specific
binding to the X-chromatin is achieved. It is known however, that the X
chromosome assumes a distinct three-dimensional conformation in the male
nucleus, and that the siRNA pathway aids in X-recognition.
We hypothesized that repetitive sequences found exclusively on the X
chromosome, called the 1.688X repeats, could be a possible source of siRNAs
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that play a role in specifying X identity, and thus promoting recognition by the
MSL complex. To test this hypothesis, I designed a functional test that detects
compensation of autosomal chromatin. This required generation of lethal
autosomal deficiencies. These were made by recombining parts of the 2nd and Y
chromosomes. These translocations can be separated meiotically to generate a
duplication and a deficiency.
I then generated a transgene carrying roX1 and 1.6883F (one of the repeat
clusters), and integrated it on an autosome. The transgene was designed such
that the role of each element could be tested individually. I discovered that all
transgenes, including 1.6883F only, recruited the MSL complex to the autosome
and increased the expression of nearby genes. When placed opposite the lethal
deficiency, the transgenes partially rescued male flies to the pharate stage.
Additionally, all transgenes led to a dramatic increase in recovery of male third
instar larvae, which was further enhanced by expression of siRNA from 1.6883F.
My findings strongly suggest that the 1.688X repeats act in cis to facilitate Xidentification and dosage compensation. They also suggest that 1.688X repeats
on the X are the targets of the siRNA pathway that contributes to X-recognition.
The close proximity and sequence similarity of the repeat clusters 1.6883F
and 1.6884A prompted us to ask if they share a redundant function in generation
of the siRNA that promotes X chromosome recognition. We discovered that flies
deleted for both repeat clusters did not show an apparent defect in male survival.
Thus the specialized role of 1.6883F, and whether it is unique from other 1.688X
repeats, remains ambiguous.
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